I. The Only Variable That Is Already Known

Almost everything in investing is a forecast. What inflation will be next year. Whether central banks will raise rates. Whether spending on artificial intelligence will continue. Whether Taiwan will stay quiet. Every one of those things is an assumption dressed up in a model.

Demographics is not an assumption.

Photo by Dominik Lange on Unsplash

The people who will be 65 in 2040 are 51 today. They already exist. They have already been counted. Nothing, not rate policy, not a technological breakthrough, not an election, can change the fact that in fourteen years they will be 65. Demographics is the only major economic variable that is not forecast but read.

And what it says about the United States is unambiguous.

By 2030, every member of the baby boomer generation, born between 1946 and 1964, will have turned 65. That is roughly one fifth of the entire population of the country. In 2025 America passed what is known as Peak 65, the year with the most people turning 65: approximately 4.2 million.

The next threshold is 2034. Census Bureau projections show that for the first time in American history, people aged 65 and over will outnumber children under 18: 77.0 million against 76.5 million. The number of Americans aged 65 and over will grow from 58 million in 2022 to 82 million by 2050, an increase of 42%, with their share of the population rising from 17% to 23%.

There is a second, sharper layer inside those numbers. It is not simply that the total number of older people is growing. The oldest group is growing fastest. The population over 80 is expected to expand at an average annual rate of roughly 5.4% between 2026 and 2030, against 1.8% a year between 2010 and 2025. That is not a smooth curve. That is an acceleration.

The ratio between workers and retirees is shifting too. In 2010 there were 22 retirees for every 100 people of working age. By 2030 that number is expected to reach 35. After that the curve levels off, reaching 37 by 2050, but the move from 22 to 35 happens inside a single twenty-year window.

This is not a forecast. This is a schedule.

II. Japan as a Warning, Not an Analogy

If you want to see what an aging economy looks like, you do not need models. You just need to look at Japan.

As of 2022, 29.9% of the Japanese population was 65 or older, nearly double the American share. By 2030 that is expected to reach 31.4%, and by 2050 fully 37.5%. Japan is roughly twenty years ahead of the United States on this measure, which makes it a natural laboratory.

The result? Japan’s health spending reaches 10.6% of GDP, against an OECD average of 9.3%. But the more important number is a different one: in 2015 people aged 65 and over, who made up about 27% of the population, generated approximately 60% of national medical expenditure.

We should be honest about the limits of the analogy. Japan has a universal health system, strong government control over prices, and a completely different payment structure. The United States spends nearly twice as much of its GDP on healthcare with a younger population. So the Japanese case is not a template America will repeat. It is evidence of direction, not of scale.

The direction is this: when a population ages, healthcare consumes a steadily larger share of the economy. And it does so permanently, not cyclically.

III. What the Research Says

The thesis that an aging population means higher health spending sounds obvious. That is precisely why it deserves to be tested rather than accepted.

Spending really is concentrated in age

The data from CMS, the American agency that runs Medicare and Medicaid, is unambiguous. In 2020, per capita health spending for people aged 65 and over was $22,356 a year. That group was about 17% of the population but generated roughly 37% of all health spending in the country.

Widen the age band and the picture gets clearer still. People aged 55 and over made up 30% of the population in 2023 but accounted for 57% of health spending. At the other end, people under 35 were 44% of the population and generated just 21% of spending.

The curve is not a straight line. It bends upward more steeply with every decade of life.

The CMS projections

The forecasting specialists at CMS expect national health spending to grow from roughly $5.9 trillion in 2026 to $8.6 trillion by 2033. As a share of the economy: from 18.6% in 2026 to 20.3% by 2033. Per capita spending is expected to rise from $16,570 in 2024 to $24,200 by 2033.

CMS states explicitly what the main driver is: people shifting out of private health insurance and into Medicare as a result of the continued aging of the baby boom generation.

Dementia as a separate curve

There is one disease whose relationship to age is so steep that it deserves to be looked at on its own.

According to the Alzheimer’s Association report for 2026, the prevalence of Alzheimer’s disease by age group looks like this: 5.2% among people aged 65 to 74, 13.8% among those 75 to 84, and 35.8% among those over 85.

Today roughly 7.4 million Americans over 65 live with dementia of this type. Absent a medical breakthrough, that number is expected to reach 13.8 million by 2060. The cost of treatment and long-term care for people with dementia is projected at $409 billion in 2026 and close to one trillion dollars by 2050.

This is a single diagnosis. What it costs in 2026 already compares to roughly 1.3 to 1.4% of American GDP, and it is moving along a curve that accelerates.

And now the counter-current, because there is one

Here we need to introduce something most analyses skip. It is not complicated, but it changes the picture.

In 1980 the American physician James Fries proposed a hopeful idea. If prevention and healthy living delay the onset of disease more than they delay death, then people will live longer but be ill for a shorter time. The period of sickness compresses. Cost per person would fall, even as life extends. This is known as the compression of illness thesis.

The opposing idea was formulated even earlier, in 1977, by Ernst Gruenberg, and argues exactly the reverse. Modern medicine handles the consequences of disease well, but in doing so it allows people to survive into ever more advanced age while accumulating more and more conditions at once. The period of sickness does not compress, it stretches. This is the expansion of illness thesis.

The real-world evidence is mixed, and that is the important part. A 2022 study in the journal Demography, tracking American generations between 1998 and 2016, concluded that successive cohorts experience neither the compression Fries predicted nor a universal expansion of time spent in poor health. The answer depends on what you measure: severe disability shows more compression, chronic disease shows more expansion.

There is a third line, and it is more uncomfortable still. In 1999 the economists Zweifel, Felder and Meier published research that became known as the red herring hypothesis. The phrase is an English idiom for a misleading trail, something that leads you in the wrong direction. Their argument runs as follows: the observed link between age and health spending is driven less by age itself than by proximity to death. A large share of what is spent on any one person is concentrated in their final months, regardless of how old they are. If that is right, an aging population by itself does not raise cost per person nearly as much as assumed. It simply pushes the same spending further out in time.

Twenty-five years of debate have not settled the question. Newer research even suggests that proximity to death is itself somewhat of a misleading trail, because it is really just a stand-in for a person’s actual state of health.

What does this mean for the investor? That the aging thesis is true at the level of total demand. More people over 65 means more doctor visits, more procedures, more prescriptions, more Medicare enrollees. But the thesis is weaker than it looks at the level of spending per patient. Demographics guarantees volume. It does not guarantee margin. That distinction becomes central in the section on risks.

IV. Anatomy of the Sector

Healthcare is perhaps the most heterogeneous of the eleven sectors in the S&P 500. Under one label live business models that have almost nothing in common. Here is how XLV breaks down by subsector, based on the fund’s composition as of 23 July 2026:

The first thing to see: this is not a balanced sector. More than half of XLV is pharmaceuticals. Hospitals, the institutions that will literally meet the silver wave at their front door, are 1.3%.

The logic of each layer is different and worth understanding, because aging does not act on them equally.

Pharmaceuticals is an intellectual property business. It earns while the patent holds and loses almost instantly when it expires. Aging increases the number of patients, but the patent calendar determines the profit. This is a sector where demand is predictable and earnings are not.

Medical devices have perhaps the cleanest link to demographics in the whole sector. An artificial joint is not a lifestyle choice, it is a necessity that arrives with age. Projections show hip replacements in the United States growing 71% to roughly 635,000 a year by 2030, and knee replacements 85% to 1.26 million. That is volume that comes directly out of the age pyramid. Yet medical devices are only 14.5% of XLV.

Lab and research equipment, companies like Thermo Fisher, Danaher, Agilent and Mettler-Toledo, is the equivalent of ASML and Applied Materials from our May analysis of semiconductors. They do not discover drugs. They sell the equipment others use to discover them. They earn from the level of research activity across the whole industry rather than from the success of any one molecule. That is a steadier profile, but it depends on the size of pharmaceutical research budgets.

Insurers are the only layer for which aging cuts both ways. More Medicare Advantage enrollees means more revenue. But older and sicker members mean higher claims paid out. An insurer does not profit from people being ill. It profits from having correctly estimated how ill they will be. This is an insurance business, not a healthcare business.

Distributors, McKesson, Cencora and Cardinal Health, work with enormous volumes and razor-thin margins. They are logistics, not medicine. Aging increases the number of prescriptions, which is directly positive for them. This is one of the most underappreciated links in the entire sector.

V. XLV: The Instrument

The State Street Health Care Select Sector SPDR ETF is the oldest and largest way to access American healthcare as a sector. The fund launched on 16 December 1998 and has lived through the dot-com bubble, the financial crisis, the Obamacare reform, COVID and the current cycle.

Two numbers in that table deserve attention, because they only appear to contradict each other.

Beta 0.57. This is the technical way of saying that when the market moves 1%, XLV moves 0.57% on average. For comparison, SMH, the subject of our May analysis of semiconductors, has a beta of 1.36. Healthcare is among the calmest sectors, alongside consumer staples and utilities. The historical data confirms it: over the period from December 1998 to May 2026 the average drop from peak for XLV was 7.64% against 11.62% for SPY, the fund that tracks the whole S&P 500.

Price return over five years: 23.65%. That is a harsh number. Five years in which the S&P 500 did many times better. Healthcare was one of the weakest performing sectors between 2022 and 2025. Its weight in the S&P 500 reached almost 16% at the end of 2022, second only to technology, and fell to 10.36% in April 2026, the lowest level since September 2000.

So: the aging thesis was true throughout that entire period and the sector still lagged badly. That is a lesson worth remembering. Certain demand is not the same as good returns.

Composition and concentration

The top five positions are 46.7% of the fund. The top ten are 62.0%. For a sector regarded as defensive and well spread, that is remarkable concentration.

And it has not always been this way. In 2020 Eli Lilly was around 4% of XLV. Today it is 16.1%, more than one dollar in every six in the fund. This change is not the result of a change in index rules. It comes down to one thing: GLP-1, the class of diabetes and weight-loss drugs that includes Mounjaro, Zepbound and Ozempic.

The companies you need to know

Eli Lilly is the sector’s centre of gravity right now, in the way NVIDIA is for semiconductors. For the first quarter of 2026 the company reported revenue of $19.8 billion, up 56% year on year. Mounjaro generated $8.7 billion for the quarter, up 125%, and Zepbound $4.2 billion, up 80%. Earnings per share came in at $8.55 against expectations of $6.66. The company raised its full-year 2026 guidance to between $82 and $85 billion in revenue. The quarter was also the first with orforglipron approved, the first drug in this class that is taken as a tablet rather than by injection.

It is worth noting, though, what Lilly is not: this is not a company whose growth comes from aging. GLP-1 drugs treat diabetes and obesity, and their market depends on lifestyle far more than on age. The largest position in the most demographically driven sector is powered by a theme that has almost nothing to do with demographics.

Johnson & Johnson is the opposite pole. Broadly spread pharmaceuticals and medical devices, decades of rising dividends, a business stretched across dozens of treatment areas. This is the position that makes XLV defensive.

AbbVie is a story about life after the patent cliff. The company lost patent protection on Humira, the best-selling drug in history, and survived because it had built Skyrizi and Rinvoq in advance. It is a textbook example of how a patent cycle is managed, and a reason AbbVie deserves attention as a model rather than merely as a holding.

UnitedHealth Group is the most interesting case at the moment. After a difficult stretch the company is recovering. The key measure here is what share of collected premiums goes out again to pay medical costs. In 2025 that share rose to 88.9%, which is very high. In the second quarter of 2026 it fell to 86.7% from 89.4% a year earlier, earnings per share reached $6.38, and full-year guidance was raised to between $19.50 and $20.00. How this is being achieved deserves to be named, though: the company is exiting unprofitable Medicare Advantage markets and expects to lose more than 3 million members in 2026. The margin is recovering through contraction, not growth.

Thermo Fisher and Intuitive Surgical represent the two infrastructure bets in the sector. One on research activity in general, the other on robotic surgery as a standard of care. Both are businesses where revenue comes from equipment already sold and the consumables that go with it, rather than from one-off sales.

VI. What XLV Does Not Capture

Honesty requires saying this too. XLV is not a healthcare fund. XLV is a fund of the healthcare companies inside the S&P 500. The difference matters, and it has four dimensions.

European pharmaceuticals are entirely absent. Novo Nordisk, AstraZeneca, Roche, Novartis, Sanofi, GSK. Not one of them is in XLV, because not one of them is in the S&P 500. This is especially sharp in the GLP-1 context: Novo Nordisk is Eli Lilly’s direct competitor in the most important drug battle of the decade, and the XLV investor participates in only one side of that duel.

Small and mid-cap biotech is almost entirely missing. XLV holds 63 companies, all large, all proven, all profitable enough to be in the S&P 500. Innovation in biotech, however, happens mostly at companies that are not yet there. An investor who wants exposure to the early stage of discovery looks at funds like XBI or IBB, not at XLV.

Long-term care and senior housing are not in the sector. This is perhaps the most ironic gap for a demographic thesis. Welltower and Ventas, the two companies that literally own the buildings an aging America will live in, are classified as real estate and sit in XLRE, not XLV. And their results are exactly what the thesis predicts: occupancy in Welltower’s operating portfolio reached 87.3% in the first quarter of 2026 against 85.1% a year earlier, and the company carries a market value above $165 billion, larger than almost any position in XLV.

Hospitals are nearly absent. HCA, Universal Health Services and DaVita together are 1.3% of the fund. If you believe the silver wave means more hospital admissions, more procedures and more strain on the system, XLV gives you almost no participation in the point where that physically happens.

Put differently: XLV captures the pharmaceutical profit from American healthcare extremely well. It captures medical devices partially. And it captures almost nothing of the care itself, the infrastructure, or the early-stage innovation.

VII. The Counter-Current

Demographics is a tailwind. It is not a guarantee. Here is what stands on the other side of the thesis, and this is the section that deserves the closest reading.

Prices are no longer free

The Inflation Reduction Act fundamentally changed the rules. For the first time, Medicare negotiates drug prices directly. The first negotiated prices took effect in 2026 for ten medicines. The third round, announced in January 2026, covers 15 drugs and for the first time includes ones administered in a clinic or hospital rather than dispensed at a pharmacy. Final prices will be published on 30 November 2026 and take effect on 1 January 2028.

The scale of the effect: negotiated prices reduce net spending on the selected drugs by an average of roughly 22%.

This is a permanent change, not a one-off event. The list widens every year. The mechanism that for decades allowed American pharmaceuticals to earn the highest margins in the world is being dismantled step by step. And the irony is precise: the same aging that increases volume also increases the political pressure on price. The more people are in Medicare, the bigger the budget problem becomes and the more inevitable regulatory intervention becomes.

The patent cliff to 2028

According to EY estimates, the twenty largest biopharmaceutical companies have roughly $180 billion of revenue exposed to patent expiry through 2028.

Two examples explain the scale. Merck’s Keytruda generated around $29.5 billion in 2024, approximately 56% of the company’s entire business, and the key patents on the intravenous version expire in 2028. Bristol Myers Squibb’s Eliquis brings in about $13 billion a year, expiring in 2027 or 2028.

Merck is 5.52% of XLV. Bristol Myers Squibb is 2.15%. This is not an abstract risk. It has a date.

The tariffs that are not really tariffs

The logical first impression is that tariffs on imported medicines ought to be good news for XLV. The fund holds only American companies. The tariff hits imports. It looks like straightforward protection in favour of exactly what you own.

The answer is “partly yes, but not for the reason you expect.” And the difference matters.

First, the legal basis. On 20 February 2026 the US Supreme Court struck down, by 6 votes to 3, the tariffs imposed under the emergency IEEPA statute. The ruling, however, touched only that particular route. Tariffs under other statutes, including Section 232 of the Trade Expansion Act of 1962, were left intact.

The pharmaceutical tariffs were signed on 2 April 2026, six weeks after the ruling, and precisely under Section 232. The administration did not use the route that was challenged. It chose the one the court left standing. The conclusion is clear: do not count on these being struck down in court.

Second, the rates themselves. The order imposes tariffs on imported patented medicines and on the active ingredients from which they are made. The headline rate is 100%. It falls to 20% for companies with approved plans to move production to the United States, reverting to 100% after four years, and to 15% for products from the EU, Japan, South Korea and Switzerland. Generic drugs, biosimilars (copies of biological medicines) and drugs for rare diseases are excluded. The measures take effect on 31 July 2026 for the largest companies and 29 September for the rest.

Third, and this is the substance. By the time the order was being signed, most of the large manufacturers had already stepped out from under it.

Fourteen of the seventeen companies the administration approached signed pricing agreements in exchange for a three-year exemption from tariffs. The list spans both sides of the Atlantic: Pfizer, Eli Lilly, Amgen, Bristol Myers Squibb, Gilead and Merck on the American side, and AstraZeneca, Novo Nordisk, Novartis, Sanofi, GSK and Roche through Genentech on the European.

This is where the most obvious bullish hypothesis collapses. If you expected the tariff to punish Novo Nordisk in favour of Eli Lilly in the fight for the GLP-1 market, it does not happen. Both signed. Both received exemptions. The competitive asymmetry the tariff appears to create was negotiated away before it took effect.

Fourth, what the exemption cost. It was not a gift. The companies paid for it in two currencies.

The first is price. The agreements require lower prices for Medicaid, direct discounts to consumers through the new TrumpRx platform, and a commitment to launch new medicines in the United States first. The second is capital. Pfizer committed to $70 billion of new US investment. Merck put up $1 billion for its first American Keytruda facility. Eli Lilly has already committed more than $50 billion to US manufacturing since 2020, including four new plants.

Look at that exchange carefully. A three-year reprieve from a tariff, paid for with permanent price concessions and tens of billions in capital expenditure. The reprieve expires. The concessions do not.

Which gives us the real conclusion: tariffs are not a separate risk to the sector. They are a continuation of the same one. The headline is trade policy, the mechanism is pricing policy. This is the same downward pressure on prices we saw with the Inflation Reduction Act, only negotiated instead of legislated.

So where do tariffs genuinely help XLV? In one direction, and it is real. Buying an exemption requires scale: lawyers, lobbying, a balance sheet that can absorb multi-billion-dollar investment, and a portfolio large enough for the administration to bother negotiating with you. The companies in XLV are precisely the ones that can. The mid-cap pharmaceutical companies and the biotechs, which as we saw are largely absent from the fund, cannot. In that sense the tariff is a barrier to entry rather than protection of a market. It favours the large at the expense of the small, and XLV holds only the large.

And one detail worth checking. Three companies have still not finalised agreements: Johnson & Johnson, AbbVie and Regeneron. Together they weigh 19.6% of XLV. Almost one dollar in every five in the fund sits in companies that have not yet paid for an exemption. Whether they sign, on what terms and at what cost, is an open question with a specific date attached: 29 September 2026.

Medicare’s solvency

According to the trustees’ annual report for 2026, the part of Medicare that pays for hospital treatment will exhaust its reserves by 2033. That is three years earlier than the 2024 report projected, which pointed to 2036.

This may be the single most important risk in the whole analysis, because it connects both sides of the thesis. The silver wave is good news for the volume of healthcare services and bad news for whoever pays for them. And in the United States the largest payer for older people is the federal government. When the arithmetic stops working, and it has a deadline, the response will be some combination of lower prices paid to hospitals and doctors, tighter eligibility criteria, and more pressure on manufacturers. None of those is good for the sector’s margins.

This is exactly where we return to the red herring. If a significant share of spending is determined by proximity to death rather than by age itself, then budget pressure will build more slowly than assumed. But by the same logic, so will the sector’s revenue. Both sides of the equation are connected.

Concentration in GLP-1

Eli Lilly is 16.1% of XLV. A large part of the entire sector’s performance over the past year comes down to one class of drugs.

Forecasts for this market keep moving. Goldman Sachs raised its estimate for the global anti-obesity drug market to roughly $114 billion by 2030, up from $101 billion, with tablet forms expected to account for about 40%. Morgan Stanley projects the wider GLP-1 market reaching around $190 billion by 2035. But the same Goldman had previously cut its forecast, from $130 billion to $95 billion, in 2025.

Forecasts that swing by tens of billions in both directions inside two years are not forecasts. They are a consensus still forming. And the XLV investor has one dollar in every six riding on the outcome.

VIII. Where the Sector Stands Now

For context, here is XLV against the other ten sectors of the American economy:

The picture is clear. Over three years healthcare is among the weakest sectors, 19.33% against 99.72% for technology. Over one year and three months it is among the strongest. The sector is recovering from a multi-year period of lagging.

Valuation reflects that. On expected earnings healthcare trades at roughly 17 to 19 times, against about 22 to 23 times for the S&P 500. That is a discount, and it is the reverse of the historical norm. In the late 1990s the sector traded at around 1.4 times the index multiple; today it is at about 0.8. XLV’s own P/E of 24.64 is higher because it reflects earnings already delivered rather than those expected. The gap between the two numbers is the expected growth.

Whether that discount is an opportunity or a fair price for regulatory risk is exactly the question the market has not yet answered.

IX. The Bottom Line

Healthcare is a rare case in investing: a sector whose long-term demand is mathematically known. The people who will fill the waiting rooms in 2040 have already been born, already been counted, and are already a specific age. There is no scenario in which this wave does not arrive.

But the last five years are a lesson in themselves. The thesis was true the whole time and the sector still lagged badly, with its weight in the S&P 500 falling to the lowest level since 2000. Known future demand is not the same as future returns. Between the two stand prices, regulation, patents, and the question of how much has already been paid.

The three things this analysis shows:

First, demographics guarantees volume but does not guarantee margin. More patients means more procedures and more prescriptions. Whether that turns into profit depends on prices. And prices in American healthcare are no longer free, and will not become freer. The same force that creates the demand also creates the budget pressure against it.

Second, XLV is not a pure demographic bet. The largest position in the fund, at 16%, is driven by a theme about metabolism rather than about age. The layers that would benefit most directly from aging, hospitals, long-term care and senior housing, are either minimal or entirely outside the fund. If you are buying XLV because of the silver wave, you are buying something that only partly overlaps with your thesis.

Third, this is a defensive position with average returns. Beta 0.57. An average drop from peak of 7.64% against 11.62% for SPY. On a comparable basis from the fund’s inception to May 2026, XLV’s annual return is about 8.2% against roughly 8.7% for SPY. A difference of around half a percentage point for considerably less turbulence. That is the trade. For some investors it is exactly what they want. For others it is not enough.

The silver wave will arrive. That is the only certain thing in this entire analysis. The question every investor has to ask is duller and more important: how much of it is already in the price, and where exactly along the chain will the profit stick.

Understanding a sector does not tell you when to buy. But it tells you something more important: what exactly you are buying. And in investing, clarity about the thesis is half the work.

Liquidity Desk | liquiditydesk.org | liquiditydesk.substack.com

Sources

• U.S. Census Bureau: Older Adults Outnumber Children (2025)

• U.S. Census Bureau: By 2030, All Baby Boomers Will Be Age 65 or Older

• Population Reference Bureau: Fact Sheet, Aging in the United States

• Peterson-KFF Health System Tracker: How much is health spending expected to grow?

• CMS: U.S. Personal Health Care Spending by Age and Sex

• Alzheimer’s Association: 2026 Alzheimer’s Disease Facts and Figures

• Demography (Duke University Press): Expansion, Compression, Neither, Both?

• Breyer & Lorenz: The “Red Herring” after 20 Years, Ageing and Health Care Expenditures

• Ageing and health-care expenditure: the red herring argument revisited

• OECD: Health at a Glance 2025, Japan

• Japan Health Policy NOW: Trends in Medical Expenditures

• KFF: Key Facts About Medicare Drug Price Negotiation

• CMS: Third Cycle of Medicare Drug Price Negotiation Program

• Healthcare Dive: Medicare insolvency date creeps forward

• Ropes & Gray: 100% On Brand, U.S. Imposes New Tariffs on Patented Pharmaceuticals

• Ropes & Gray: Supreme Court Strikes Down IEEPA Tariffs, Key Takeaways for Importers

• Congressional Research Service: Supreme Court Rules Against Tariffs Imposed Under IEEPA

• Pharmaceutical Technology: Trump administration ties pricing deals with another nine pharma companies

• AJMC: Trump Strikes 9 New Pricing Agreements as Drugmakers Navigate Tariff, Regulatory Pressure

• Forbes: TrumpRx Has Signed Deals With Nearly Every Major Drugmaker. Are Prices Actually Falling?

• Eli Lilly: First-Quarter 2026 Financial Results

• Eli Lilly: Plans to more than double U.S. manufacturing investment since 2020

• Goldman Sachs: The anti-obesity drug market

• Morgan Stanley: GLP-1 Market Expected to More Than Double to $190B by 2035

• Stock Analysis: XLV ETF Overview

• State Street: XLV Fund Page

• PR Newswire: Projected Volume of Primary and Revision Total Joint Replacement in the U.S.

• Senior Housing News: Welltower Q1 2026 occupancy

Rate markets had a much rougher week than credit markets did. A sudden repricing of what the Fed does next sent bond volatility through a level it has not touched in months, while credit spreads kept quietly grinding tighter as if nothing happened. Full breakdown below for paid subscribers.

Read more

American drivers are still paying just under $4 per gallon, but the wholesale market is already warning that the relief may be temporary. The June ceasefire restored some oil flows through the Strait of Hormuz, but it did not fully restore refinery operations or refined-product exports. After strikes resumed in July, WTI moved back above $82, gasoline futures rose 13% for the month, and the diesel benchmark gained almost 30%. At the same time, wheat is trading close to $7 per bushel because the smallest Hard Red Winter crop since 1957/58 has nothing to do with the daily news cycle. The Federal Reserve is caught between renewed energy inflation and a labour market that is weaker than the 4.2% unemployment rate suggests. The problem is no longer just the price of crude oil. Fuel, food, and production costs are passing through to the economy at different speeds.

Oil is pricing in the failed ceasefire. Wheat never priced in the peace.

1. Energy: Crude Rebounded, but Refined Products Never Normalised

Pump prices still look relatively calm, but wholesale markets are tightening again. On 17 July, the US national average for regular gasoline stood at $3.981 per gallon according to AAA. That is just below the politically sensitive $4 threshold, but the wholesale price has already started moving in the opposite direction.

WTI reached $82.49 per barrel and Brent $88.10. In one week, the two benchmarks rose 15.52% and 15.91%, respectively. The move is not being driven by a sudden recovery in global demand. It reflects the return of the Hormuz risk premium after the June ceasefire failed and the United States and Iran resumed exchanging strikes.

June showed how quickly the physical picture can change. The International Energy Agency reported that global oil supply rebounded by 4.1 million barrels per day to 98.8 million barrels per day after some traffic through the Strait resumed. Gulf exports, including volumes using bypass routes, climbed to 16.1 million barrels per day. That was a strong recovery, but still well below the pre-war average of about 24 million barrels per day.

The more important split is between crude oil and finished fuels. More crude reached the market in June, but refinery operations and product exports recovered much more slowly. According to the IEA, global refinery runs remained 6 million barrels per day below the previous year’s level, while Gulf exports of refined products were less than half their pre-war volume. Crude can therefore look relatively well supplied while gasoline and diesel remain scarce.

The divergence is visible in prices. RBOB Gasoline, the US wholesale gasoline futures benchmark, trades at $3.3927 per gallon and is up 13.28% for the month. NYMEX HO, the contract for New York Harbor Ultra-Low Sulfur Diesel, or ULSD, trades at $4.0646 per gallon. It is up 29.97% for the month and 65.70% over the past year. The contract is historically called Heating Oil, but the commodity delivered today is low-sulphur diesel.

Henry Hub is telling a different story. US natural gas trades at $2.911 per MMBtu, down 9.96% for the month and 18.35% over the past year. The United States has substantial domestic production, and natural gas cannot leave the country without first being liquefied at an LNG terminal. That infrastructure constraint partially isolates Henry Hub from the global shock. The isolation is gradually weakening as US LNG export capacity expands.

2. Commodity Dashboard

Market data primarily as of 17 July 2026. The CRB Index is as of 16 July and Urea as of 14 July. Prices and percentage changes are from Trading Economics unless otherwise stated.

The dashboard shows three different markets. Crude oil carries a renewed geopolitical premium. Finished fuels face a physical refining constraint. Agriculture has its own story of reduced acreage, a smaller crop, and lower stocks. The common denominator is inflationary pressure, but each market passes that pressure through to consumers at a different speed.

One clarification matters for the Baltic Dry Index. It measures shipping costs for dry bulk cargo such as grain, iron ore, and coal. It does not measure oil tanker rates. Its reading above 2,700 points shows that physical commodity trade remains active, but it cannot be used as a direct measure of transport conditions through Hormuz.

3. The Transmission Chain: Four Channels, Four Different Lags

Channel 1: Crude Oil to the Gasoline Pump

The American driver is not yet paying the full price of the July escalation. The $3.981 national average is a retail price that includes crude oil, refining, taxes, distribution, and the retailer’s margin. RBOB at $3.3927 is a wholesale futures price. The two prices are not directly comparable, and they do not move at the same time.

The usual lag from crude and wholesale gasoline to the pump is roughly two to three weeks. If RBOB remains above $3.30, the national average is likely to move back above $4 even if WTI stays below $90. That threshold carries more political weight than most economic indicators because households see and pay it directly every day.

Channel 2: ULSD to Transport and Store Prices

The strongest inflation signal in the July data is not WTI. It is ULSD at $4.0646 per gallon. Diesel costs are embedded in almost every physical product, whether through trucking, rail freight, farm machinery, or backup generation.

Transport companies do not rewrite every contract on the day a futures price rises. Fuel surcharges and new contract rates pass through gradually, usually over six to ten weeks. July’s move should therefore become more visible in goods prices and services inflation during August and September.

This also explains why June’s crude oil decline did not solve the problem. Refining margins expanded because the market received more crude but not enough finished gasoline, diesel, and jet fuel. Until that imbalance clears, a lower Brent price will not pass through to consumers one for one.

Channel 3: Natural Gas to Fertiliser, Harvest, and Food

More expensive food in 2027 may result from a decision a farmer made in the spring of 2026. Nitrogen fertiliser starts with natural gas. Through the Haber-Bosch process, gas is used to produce ammonia, which is then converted into Urea.

The global urea benchmark recovered to $420 per ton, up 13.51% for the month. The July Urea FOB US Gulf futures contract trades near $379 per ton. The difference reflects distinct regional benchmarks and delivery terms, but both remain below the $480 to $500 zone where demand would normally begin to stabilise.

A low price does not necessarily mean a good outcome. Farmers already faced high prices and uncertain deliveries during March and April. If some of them reduced nitrogen application, a decline in price after planting cannot make up for fertiliser that was never applied. The consequences appear months later in yield, protein content, and ending stocks.

The acreage data are consistent with that caution, although they do not prove the cause on their own. The USDA estimates US corn acreage at 95.3 million acres, down 3% from 2025. Soybean acreage is estimated at 85.4 million acres, up 5%. Soybeans require substantially less applied nitrogen than corn. Total wheat acreage is estimated at 42.7 million acres, down 6% from a year earlier.

Channel 4: Oil to Biofuels and the Grain Price Floor

Corn and soybeans have a major source of demand that matters far less for wheat: the energy sector. The US Renewable Fuel Standard creates minimum demand for corn-based ethanol and soybean-based biodiesel. That mandated demand remains even when oil becomes cheaper.

Additional economic demand, however, depends on the price. When WTI trades above roughly $90, biofuels become more competitive with conventional fuel. At $82.49, that incremental incentive is not yet fully active. Corn at $4.45 per bushel is therefore an important intermediate signal. A break above $4.50 alongside WTI above $90 would show that the energy channel is amplifying the agricultural one again.

4. Wheat Is Not Following Oil

For flour buyers, the June ceasefire made little difference. US wheat gained 12.71% for the month to $6.83 per bushel and is now almost 25% above its level a year ago. The move is not coming from Hormuz. It is coming from the American harvest.

The USDA’s July Wheat Outlook confirms the scale of the problem. Total US wheat production for 2026/27 is forecast to fall 23% from the previous year. Hard Red Winter wheat, a class widely used for bread flour, is heading for its smallest crop since 1957/58.

Even with Hard Red Winter exports forecast to decline 35% and domestic use expected to weaken, ending stocks for the class are still projected to fall 30%. Total US wheat ending stocks are forecast at 722 million bushels, down 21% and at a three-year low.

That is the important difference between a temporarily high price and a physically tight balance. The market can remove an oil risk premium in one day after a diplomatic announcement. Diplomacy cannot create an additional harvest after the season is over.

The futures curve also offers no sign of rapid relief. The latest available Chicago Soft Red Winter Wheat quotes place September delivery near $6.21, December near $6.35, and March 2027 near $6.48 per bushel. Each successive delivery is more expensive than the one before it. This structure is called contango. Part of the difference reflects storage and financing costs, so the curve alone does not prove scarcity. It does show that the market does not expect later-dated prices to fall quickly and remain lower.

The next threshold is $7 per bushel. A sustained move above it would confirm that limited supply has become more important than the selling pressure associated with the current harvest. A return below $6.20 would be the first sign that the market priced the risk too aggressively.

5. CRB Index: The Correction Did Not Break the Cycle

The broad commodity market is again approaching the zone that separates a correction from a renewed advance. The CRB Index stands at 480.72 points, up 3.47% for the month and 28.37% for the year. It remains below the wartime peak near 516, but well above the 450 area reached during the June ceasefire.

CRB is not an oil index. Approximately 39% of its weight comes from energy and 41% from agricultural commodities. The remainder is divided between industrial and precious metals. This composition explains why June’s oil decline did not push the index below 400 and why the current rise in wheat matters for the broader picture.

A full commodity-cycle reversal would require energy, agriculture, and transport costs to fall at the same time. WTI would move below $70, wheat below $6, the Baltic Dry Index below 1,500, and CRB below 400. None of those conditions is present.

The current move looks more like a correction within an ongoing cycle. Energy fell after Hormuz partially reopened, but finished fuels remained tight, wheat continued higher, and dry bulk transport costs stayed elevated. A break above 500 in the CRB would confirm a renewed broad advance. A decline below 450 would restore the case for gradual normalisation.

Historical comparisons do not support a full collapse either. Commodities crashed in 2008 because of a credit breakdown. The 2022 correction followed the fastest monetary tightening in decades. In July 2026 there is neither a credit crash nor a new aggressive rate-hiking cycle. There is a continuing supply shock and an economy showing increasingly visible signs of slowing.

6. The Fed: Inflation Fell in the Rear-View Mirror. The Risk Ahead Is Rising Again.

For American households, the June inflation report brought welcome relief. The Consumer Price Index fell 0.4% from May, while the annual rate slowed to 3.5%. Core CPI, which excludes food and energy, was unchanged for the month and slowed to 2.6% year on year.

Those figures describe June’s decline in oil, not its July recovery. Energy prices fell 5.7% in one month but remained 15.7% higher than a year earlier. Gasoline was 26.7% above its year-ago level, while fuel oil was 42.9% higher.

Producer inflation is more concerning. The Producer Price Index fell 0.3% in June but remained 5.5% higher than a year earlier. In May, the Federal Reserve’s preferred PCE inflation measure stood at 4.1%, with core PCE at 3.4%. Falling energy temporarily pulled consumer inflation lower, while accumulated production costs continued moving through the supply chain towards final prices.

The Federal Reserve is holding its target range at 3.50% to 3.75%. Its June projections showed higher expected inflation and a higher projected policy rate at year-end 2026 than in March. That is not a promise of another increase, but it shows that the central bank does not consider the inflation risk resolved.

Recent statements confirm that caution. Lorie Logan argued for keeping rates moderately high and warned that one month of lower inflation is not enough. Lisa Cook said she was prepared to act if sustained signs of disinflation did not emerge. Philip Jefferson focused on how the Middle East conflict, higher oil prices, and disrupted supply chains complicate the Fed’s dual mandate.

Low Unemployment Without a Strong Labour Market

An unemployment rate of 4.2% appears to suggest that the economy can absorb higher interest rates. The details behind the headline say otherwise.

In June, household-survey employment fell by 507,000. The labour force contracted by 720,000, while the number of people outside it increased by 832,000. The labour-force participation rate fell from 61.8% to 61.5%, its lowest level since March 2021. The employment-to-population ratio declined from 59.2% to 59.0%.

Unemployment therefore fell from 4.3% to 4.2% not because more people found work, but partly because some people without jobs were no longer counted as actively looking. The establishment survey recorded only 57,000 new payroll jobs in June, while April and May were revised down by a combined 74,000.

Not everyone leaving the labour force is a discouraged worker. Part of the longer-term contraction reflects population ageing and lower net immigration. But participation among people aged 25 to 54 also fell, from 83.9% to 83.3%. The weakness cannot therefore be explained by retirement alone.

The Federal Reserve faces a genuine two-sided risk. The renewed rise in fuel prices argues against rate cuts. Weak employment and labour-force exits argue against a hasty increase. The most likely response is to hold rates while policymakers assess whether July’s energy rise becomes persistent inflation and whether the labour market continues to weaken beneath the headline numbers.

7. What We Are Watching Over the Next 30 Days

The market is paying a geopolitical risk premium again, but it is not yet pricing a complete supply disruption. WTI at $82.49 and Brent at $88.10 sit between two regimes: too high for a normalised market, but still below the levels that would confirm a renewed, acute physical supply crisis.

Confirming Signals: A Renewed Energy Shock

• WTI above $90 for at least five consecutive sessions by mid-August. This would show that the market sees a lasting loss of physical supply rather than a short military escalation.

• Brent above $95 by mid-August. The international benchmark is more directly exposed to Hormuz. A sustained break higher would mean bypass routes and reserve releases are not compensating for the disruption.

• HO/ULSD above $4.00 per gallon for the next two weeks. The threshold has already been reached. Holding above it would mean renewed transport pressure feeding into physical goods prices during August and September.

• CRB Index above 500 by the end of July. This would show that the move is no longer confined to oil and is spreading across the broader commodity basket.

Normalisation Signals

• WTI below $75 alongside rising traffic through Hormuz. A price decline alone is not enough. It must be accompanied by independently confirmed improvement in shipping activity.

• HO/ULSD below $3.50. This would interrupt the renewed rise in logistics costs, although the previous increase would remain embedded in contracts for several more weeks.

• CRB Index below 450. Below this level, the move would begin to resemble a broad commodity correction rather than the removal of an oil-specific geopolitical premium.

• CBOT Wheat below $6.20 per bushel. The current level near $6.83 shows that wheat is trading on its own fundamentals. A decline below $6.20 would challenge the case for persistently limited supply.

The Separate Grain Signal

CBOT Wheat above $7 per bushel by mid-August would confirm that wheat has decoupled from energy. It would show that drought, the weak Hard Red Winter crop, and lower stocks are sufficient to support the price even if oil becomes cheaper.

Scenario Framework

The base case is Scenario A, but it does not assume a return to the extreme prices reached in the spring. The conflict is restricting shipping again, but partially restored production, inventories, and bypass routes are keeping Brent below its previous peak. The decisive test is whether WTI breaks $90 and whether ULSD remains above $4.

Wheat remains a separate story. Above $7, it would show that even an oil normalisation would not be enough to remove the risk to food prices.

Oil can lose its war premium in a day. A ceasefire cannot recover a lost harvest.

Primary Sources

• Trading Economics: energy, agriculture, Urea, CRB, and Baltic Dry Index prices, 14 to 17 July 2026.

• AAA Fuel Prices: US national average gasoline price, 17 July 2026.

• International Energy Agency, Oil Market Report, July 2026.

• U.S. Energy Information Administration, Weekly Petroleum Status Report, week ending 10 July 2026.

• USDA Economic Research Service, Wheat Outlook, July 2026.

• USDA NASS, Acreage Report, 30 June 2026.

• U.S. Bureau of Labor Statistics, CPI, PPI, and Employment Situation, June 2026.

• U.S. Bureau of Economic Analysis, Personal Income and Outlays, May 2026.

• Federal Reserve, Monetary Policy Report and Summary of Economic Projections, June and July 2026.

This publication is for informational and educational purposes only. It does not constitute investment advice, a recommendation, or a solicitation to buy or sell any financial instrument. Past performance is not indicative of future results. Every investor should conduct independent research and assess their personal tolerance for risk.

The funding-stress watch we have been flagging for weeks finally turned the corner again this cycle, and rate volatility eased right alongside it. Credit markets stayed calm throughout, content to keep drifting in the same direction they have been for over a month now. Full breakdown below for paid subscribers.

Read more

June was a month of differentiation. European technology caught up with the US, Health Care led in America, and Latin America absorbed the full pressure of a stronger dollar. The market was not abandoning risk altogether. It was choosing where to carry it.

In July, that selectivity remains, but the leadership has changed. The reopening of oil flows through the Strait of Hormuz initially removed part of the geopolitical premium that had supported energy, while financial companies took the lead on both sides of the Atlantic. Renewed attacks on commercial shipping have since made that de-escalation fragile. Technology has not disappeared as a structural theme, but investors are no longer treating every technology market as the same trade.

The change is visible beyond developed markets. Latin America has moved from broad losses to broad gains even though the dollar remains firm. Asia is split between semiconductor strength, a Japanese recovery, an Indian rebound, and continued weakness in China. The result is a market that is calmer, broader, and more willing to reward local fundamentals.

The central question this month is therefore not whether investors want risk. They do. The question is what kind of risk they are willing to own when long-term borrowing costs remain high and the dollar still acts as a constraint on global capital flows.

Macro Context

Rate Environment

The Federal Reserve continues to hold its target range at 3.50% to 3.75%, with the effective federal funds rate around 3.63%. The 10-year US Treasury yield stood at 4.54% on 9 July, leaving long-term market rates roughly 0.91 percentage points above the effective policy rate. This positive spread matters because banks fund themselves at shorter maturities and lend or invest further out on the curve. A higher long rate relative to the policy rate can support interest margins, provided credit losses remain contained. The next FOMC meeting is scheduled for 28 and 29 July.

The European Central Bank has already delivered the move that markets were anticipating in June. It raised the deposit facility rate by 0.25 percentage points to 2.25%, effective 17 June, in response to renewed inflation pressure from the Middle East energy shock. A new 10-year German federal bond cleared its 8 July auction at an average yield of 3.09%, about 0.84 percentage points above the ECB deposit rate. That combination, a higher policy rate and a positive long-end spread, helps explain why European banks, insurers, and financial services dominate this month’s ranking. The ECB meets again on 22 and 23 July.

Japan has also moved. The Bank of Japan raised its policy rate from 0.75% to 1.00% in June, while the average yield at the 7 July auction of 30-year Japanese government bonds reached 3.993%. The gap between the policy rate and the 30-year yield is therefore almost three percentage points. This is the real Japanese rate story. The carry trade means borrowing cheaply in yen and investing in higher-yielding assets elsewhere. As Japanese rates rise, that trade becomes less attractive, capital can return home, and the yen becomes less reliable as a source of cheap global funding. The next BOJ meeting is on 30 and 31 July.

The Broad Dollar

The Federal Reserve’s Broad Dollar Index, which tracks the dollar against a trade-weighted group of major US partners, stood at 120.6902 on 2 July, up from 119.0359 on 2 June. That is a monthly increase of roughly 1.39%.

A stronger dollar works through two main channels. It reduces the translated value of foreign earnings for US multinationals, and it raises the local-currency cost of servicing dollar-denominated debt in emerging markets. In June, the second channel overwhelmed Latin America. In July, however, the region rebounds despite the same currency headwind. That divergence is important: the dollar remains restrictive, but local valuations and country-specific stories have become strong enough to attract selective buyers.

Risk Appetite

The VIX, a measure of expected US equity-market volatility and a practical gauge of investor fear, closed at 15.84 on 9 July, down from 19.87 one month earlier. Readings below 20 generally indicate calm, above 20 signal elevated nervousness, and above 30 are associated with active fear or panic.

The fall of roughly 20% in the VIX confirms that July’s recorded rotation is not a defensive retreat. Investors became more comfortable with risk as oil flows recovered and the immediate market impact of the Middle East shock eased. The latest attacks in and around the Strait of Hormuz, however, occurred close to or after the ETF data cutoff. A calm VIX therefore describes the pricing captured in the tables, not a guarantee that geopolitical risk has disappeared.

Geopolitical Energy Context

The energy story has two distinct phases. The first was de-escalation. A June agreement between the United States and Iran supported a strong recovery in tanker traffic through the Strait of Hormuz. The International Energy Agency reported that benchmark oil prices continued to fall as flows recovered, while the US Energy Information Administration said Brent averaged $85 per barrel in June, $22 below May and $32 below its April peak. The EIA consequently raised its production forecast and assumed that oil output and trade flows would move back toward pre-conflict levels by year-end.

The second phase began in early July. New attacks on commercial vessels, renewed US strikes on Iran, and Iranian retaliation against US-linked targets and Gulf states put the ceasefire framework under pressure again. The Strait matters because roughly one-fifth of globally traded oil and natural gas passed through it before the war. Even without a complete closure, higher insurance costs, tanker diversions, slower loading, and the reluctance of crews to enter the corridor can tighten physical supply.

This timing is essential for reading the ETF returns. The rolling one-month data still carry the large price decline created by the initial reopening, which is why US Energy and European Oil & Gas are both down about 4%. The renewed escalation arrived near the end of the measurement window and, in part, after markets had closed for the weekend. The negative monthly return therefore does not mean geopolitical risk is resolved. It means the market’s base case shifted toward restored flows before the tail risk returned. If transit deteriorates again, energy could reverse sharply even while the rest of the market remains calm.

United States: Sector Rotation

The main US signal in July is a shift from shock-sensitive leadership to rate-sensitive leadership. Financials (XLF) lead with +6.20%, accelerating sharply from +2.38% in June. The mechanism is straightforward: the effective policy rate remains below the 10-year Treasury yield, which creates a more supportive curve for bank margins. The one caution is the longer view. XLF is nearly flat over six months, so July looks like a rotation into the sector rather than confirmation of a fully established trend.

Health Care (XLV, +4.06%) remains near the top after leading in June. This continuity matters more than the slight loss of rank. Ageing populations in the US, Europe, and Japan create structurally rising demand for medical services, pharmaceuticals, and devices. Investors are still paying for that predictability, even as the VIX falls and broader risk appetite improves.

Industrials (XLI, +3.60%) deliver one of the clearest reversals in the US table, moving from a monthly loss in June to third place in July. Their 6-month and 1-year returns, +12.35% and +21.36%, show that this is more than a one-month bounce. A calmer volatility backdrop and resilient capital spending are helping cyclicals that can absorb higher financing costs.

Utilities (XLU, +3.25%) also recover, but the 3-month return remains negative. That combination suggests a short-term bid for stable cash flows rather than a decisive structural breakout. Technology (XLK, +2.77%) continues to advance and still carries the strongest 3-month return in the group at +30.77%. The sector has cooled from its earlier surge without breaking the longer AI and semiconductor trend.

Energy (XLE, -4.03%) has moved from second place in June to last place in July. This is the sharpest reversal in the US ranking. The sector still shows +18.02% over six months and +25.10% over one year, so the longer energy cycle is intact. Most of the monthly decline reflects the reopening trade and the fall in crude prices from their spring peak. The latest attacks complicate that interpretation: US producers retain direct upside if Hormuz traffic deteriorates again, and record demand for US petroleum exports during the earlier disruption showed how quickly global buyers can shift toward American supply.

Summary: US leadership has rotated from Health Care and Energy toward Financials and Industrials. Technology remains structurally strong, while Energy gives back its June geopolitical premium.

Europe: Sector Rotation

Europe provides the clearest signal in the entire July dataset: higher rates are transferring leadership directly to the financial complex. Banks (EXV1) rise 12.34% for the month, up from only 1.02% in June, and now show +43.34% over one year. This is not just a monthly bounce. European banks have become one of the strongest established trends in the global rotation map.

Insurance (EXH5, +10.16%) and Financial Services (EXH2, +6.30%) confirm that the move is broader than banks alone. Insurers benefit when higher yields improve the returns available on their bond portfolios, while financial services gain from stronger market activity and asset values. The important contrast is with US Financials: both regions benefit from supportive yield curves, but Europe has the stronger monthly move because the ECB has just raised rates while the Fed remains on hold.

Travel & Leisure (EXV9, +6.54%) continues to perform as the summer season strengthens demand. The sector has now returned +10.63% over three months, giving the move more credibility than a single seasonal spike. Food & Beverage (EXH3, +5.71%) and Health Care (EXV4, +4.77%) add a defensive layer to the rally, while Industrial Goods & Services (EXH4, +3.91%) shows that investors are also willing to own selected cyclicals.

European Technology (EXV3, -1.85%) is the most important reversal. It led June with +10.8%, then slipped into negative territory in July. The 3-month return remains +20.59%, so this looks like consolidation after a rapid catch-up rally rather than a collapse in the European AI thesis. US Technology, by contrast, stays positive. The global technology cycle remains intact, but the short-term catch-up trade has paused in Europe.

At the bottom, Basic Resources (EXV6, -6.03%), Telecommunications (EXV2, -5.72%), Oil & Gas (EXH1, -3.88%), and Automobiles (EXV5, -3.43%) all lag. Basic Resources still show +57.10% over one year, which makes the current decline a correction from strength. Automobiles are different: negative returns across one, three, six, and twelve months point to persistent structural pressure from Chinese electric-vehicle competition, a slow domestic transition, and weak pricing power.

The Energy comparison is now symmetrical. US XLE falls 4.03% and European EXH1 falls 3.88%. In June the regions diverged sharply, but in the current rolling window they agree because the reopening of Hormuz reduced crude prices for both. The symmetry may not last. A renewed supply shock would probably support US producers more directly, while European majors would still face heavier regulation, taxation, and euro-based costs. Europe would also absorb more of the inflation damage from expensive imported energy.

Summary: Europe has rotated decisively into banks, insurance, and financial services. Technology pauses after June’s catch-up surge, while autos remain structurally weak and energy loses its risk premium.

Asia: Country Rotation

In Asia, country-level analysis remains more informative than sector-level analysis because regulatory systems, currencies, and economic cycles differ too widely for a single sector label to explain the region. Taiwan, Japan, India, and China are all responding to different domestic forces even when they share the same global backdrop.

Taiwan (EWT, +5.35%) leads again, strengthening from +3.22% in June. Its 3-month return is +38.97% and its 1-year return is +82.99%. TSMC and the broader semiconductor supply chain keep Taiwan at the centre of the AI capital-expenditure cycle. Unlike European Tech, which pauses after its June catch-up, Taiwan continues to attract capital without interruption.

Japan (EWJ, +3.96%) reverses its June decline despite the BOJ rate increase and the rise in long-term JGB yields. This is a constructive signal. It suggests that investors are beginning to distinguish between the pressure that higher rates place on the carry trade and the domestic benefits of monetary normalisation, including better returns for financial institutions and a healthier pricing environment. The risk remains that a sharper yen appreciation could force more carry positions to unwind.

India (INDA, +3.70%) also reverses its June loss. The recovery is welcome, but the longer context is still weak: the ETF is down 7.29% over six months and 11.43% over one year. July therefore looks like a rebound from stretched pessimism, not yet a full restoration of India’s former status as the preferred emerging-market alternative to China.

South Korea (EWY, -0.29%) is nearly flat after a modest June decline, but the long-term numbers remain exceptional: +68.54% over six months and +154.61% over one year. Samsung and SK Hynix keep the market tied to the memory-chip cycle. A pause after a move of this size is healthy until the longer trend shows evidence of breaking.

China remains the clear laggard. MCHI falls 2.15% and FXI loses 3.49%, with both ETFs down roughly 15% over six months. The weakness is broad rather than limited to a particular group of large companies. Soft domestic demand, persistent deflationary pressure, geopolitical risk, and a firm dollar continue to keep international capital cautious.

Summary: Taiwan remains Asia’s structural leader, while Japan and India rebound. South Korea consolidates after an extraordinary run. China remains the region’s persistent weak point.

Latin America: Country Rotation

Latin America delivers July’s most surprising regional reversal. Every ETF in the group is positive even though the Broad Dollar Index is still higher than a month ago. A firm dollar normally compresses commodity-linked revenues relative to expectations and increases the local-currency burden of dollar debt. The fact that the region rises anyway indicates that June’s selling created room for a valuation rebound and that investors are returning selectively rather than making a broad macro bet against the dollar.

Brazil (EWZ, +5.93%) moves from the worst market in June to the best market in July. This is a powerful monthly reversal, but the 3-month return remains -11.37%. Brazil is therefore recovering from a deep drawdown, not yet confirming a new structural uptrend. Fiscal credibility, high real interest rates, and political uncertainty remain the domestic variables that can either extend or end the rebound.

The regional benchmark ILF rises 3.88%, confirming that the recovery is broader than Brazil alone. Its 1-year return of +33.04% shows that Latin America still offers a strong longer-term return profile despite the recent volatility.

Chile (ECH, +2.68%) rebounds with the region, but the 6-month return remains negative. Because Chile is closely tied to copper, its next move depends heavily on Chinese industrial demand. The continued weakness in Chinese equity ETFs argues for some caution even as Chile recovers locally.

Argentina (ARGT, +1.79%) remains positive for a second month. Its reform thesis, built around fiscal consolidation and currency liberalisation, continues to give the market an independent source of demand. The decoupling is less dramatic than in June because the rest of the region is now rising too, but the persistence of positive returns still matters.

Mexico (EWW, +0.13%) is technically positive but clearly the regional laggard. Its proximity to the United States remains a long-term trade advantage, while tariff policy and future USMCA negotiations continue to create a valuation discount. Investors are returning to Latin America, but they are still hesitant to pay for Mexico’s specific policy risk.

Summary: Latin America rebounds across the board despite a firm dollar. Brazil leads the recovery but remains weak over three months. Argentina’s reform story persists, while Mexico barely participates.

Rotation Signal and Conclusion

Global capital is moving back toward cyclical and rate-sensitive assets, but it is doing so selectively rather than indiscriminately.

This is not panic and it is no longer primarily a defensive repositioning. A VIX below 16 signals that the market was calm at the data cutoff. Health Care remains strong, but Financials, Industrials, European Banks, and Travel are now participating. The breadth of leadership is wider than it was in June, even as the latest Hormuz events create a new risk that may not yet be fully reflected in prices.

Three themes dominate the July rotation.

The first is financial leadership under high long-term rates. US Financials rise 6.20%, European Banks gain 12.34%, European Insurance climbs 10.16%, and Financial Services add 6.30%. The common mechanism is the shape of the yield curve and the higher return available on financial assets. Europe has the stronger expression because both the ECB policy rate and the German long end have moved higher, while the Fed remains on hold.

The second is a two-stage energy repricing. US Energy and European Oil & Gas fall by almost the same amount after diverging in June because recovering Hormuz flows and lower crude prices removed part of the shock premium. Renewed vessel attacks and military escalation now put that assumption at risk. Energy is not simply a losing sector this month. It has become an event-driven position with a negative recorded return and renewed upside optionality if physical supply is disrupted again.

The third is a more selective emerging-market recovery. Latin America rebounds despite a stronger dollar, Taiwan extends its semiconductor leadership, Japan and India recover, but China remains negative. Investors are not buying emerging markets as one category. They are rewarding markets with an identifiable domestic or structural catalyst and avoiding those where the growth narrative remains unresolved.

The quiet signal is the gap between market volatility and physical energy risk. A VIX below 16 says equity investors were calm, while renewed attacks on a corridor that normally carries about one-fifth of traded oil and gas say the supply tail risk remains unusually large. This disconnect can persist, but it cannot be ignored. If shipping conditions worsen, the first transmission will be through oil and gas prices, followed by inflation expectations, long-term yields, and rate-sensitive sectors.

European automobiles provide a second structural signal. In a month when risk appetite improves and most European sectors rise, the sector still falls and remains negative across every major time horizon. That is not ordinary cyclical noise. It is evidence that Chinese EV competition, weak pricing power, and a slow domestic transition are becoming structural rather than temporary problems.

July’s rotation is broader and calmer than June’s, but it is not careless. Investors are willing to own banks, industrials, selected emerging markets, and semiconductor exposure while long rates remain high. They are unwilling to rescue structurally weak sectors simply because the VIX has fallen.

The key variables for the next month are Hormuz transit and the sequence of central-bank meetings: the ECB on 22 and 23 July, the Fed on 28 and 29 July, and the BOJ on 30 and 31 July. The energy route will determine whether inflation pressure returns, while the central banks will determine whether financial leadership can continue, whether the dollar tightens further, and whether Japan’s return to positive rates stays orderly.

Liquidity Desk | liquiditydesk.substack.com

Data and Macro Sources

• ETF performance: StockAnalysis.com, retrieved on 12 July 2026. Returns are rolling performance figures as displayed by the source:

• https://stockanalysis.com/

• Federal Reserve and US rates: https://fred.stlouisfed.org/series/DFF and https://fred.stlouisfed.org/series/DGS10

• Broad Dollar Index: https://fred.stlouisfed.org/series/DTWEXBGS

• VIX: https://fred.stlouisfed.org/series/VIXCLS

• FOMC calendar and June minutes: https://www.federalreserve.gov/monetarypolicy/fomccalendars.htm

• ECB June decision and meeting calendar: https://www.ecb.europa.eu/press/pr/date/2026/html/ecb.mp260611~4d41bd5e83.en.html and https://www.ecb.europa.eu/press/calendars/mgcgc/html/index.en.html

• German 10-year bond auction: https://www.bundesbank.de/resource/blob/1001730/ea4bee93711e9a5f41f43ff162fa5552/472B63F073F071307366337C94F8C870/2026-07-08-tenderergebnis-download.pdf

• Bank of Japan policy and calendar: https://www.boj.or.jp/en/ and https://www.boj.or.jp/en/about/calendar/index.htm

• Japan 30-year government bond auction: https://www.mof.go.jp/english/policy/jgbs/auction/calendar/eresul/eresul20260707.htm

• IEA July Oil Market Report: https://www.iea.org/reports/oil-market-report-july-2026

• EIA July Short-Term Energy Outlook and revised production forecast: https://www.eia.gov/pressroom/releases/press590.php and https://www.eia.gov/outlooks/steo/report/global_oil.php

• Latest Strait of Hormuz developments at the data cutoff: https://apnews.com/article/72181b48494a6367c40cf6e9a817e6b4 and https://apnews.com/article/0764d17c09370a8c5cf1e8197a8878ab

Rate volatility crept back into the picture this week, but credit markets barely blinked. One funding indicator we have flagged for weeks finally took a breather, while the broader credit backdrop kept easing underneath it. What that divergence means, and where the regime lands, is broken down below for paid subscribers.

Read more

Every Friday, Credit Pulse tracks six indicators across rate volatility, short-term funding, and credit risk to read where the market really stands - not where the headlines say it stands. This week both rate markets and credit markets eased together, with one indicator still worth watching closely.

CREDIT REGIME THIS WEEK

Read more

Introduction

On July 3, 2026, a state funeral began in Tehran for Supreme Leader Ali Khamenei, killed on February 28 in Israeli and U.S. airstrikes. The ceremony comes three weeks after Trump and Pezeshkian signed a memorandum of understanding ending the war, during a dinner with Macron at Versailles following the G7 summit. On June 18, Pakistan announced that the Strait of Hormuz would reopen immediately and that the U.S. naval blockade would end. Since July 1, ships have been crossing the strait again.

But as CSIS noted in its analysis published on July 1, this is not a peace settlement. It is an extended ceasefire, still hostage to the same dynamics that drew the two sides into conflict in the first place. Free passage through the strait holds only for sixty days, after which Iran intends to charge tolls that Washington has already flatly refused to accept. The wound at Hormuz, the one we wrote about in the May edition, is no longer bleeding. It has been stitched, with thin thread, hastily laid under the pressure of that sixty day window.

Right as the conflict escalated through the spring, three of the world’s four most influential central banks actually tightened policy, each one citing inflation risk stemming directly from the war. Now the war is winding down, but the tightening remains a fact. In this edition we look at what actually happened to liquidity over the past month, how far private credit is compensating for the new tightening, and whether the stitches will hold while we wait to see if the inflation data vindicates the rate hikes, or shows that central banks acted late on a cause that is already fading.

Block 1: Central Banks

1.1 Federal Reserve (United States)

The Fed’s balance sheet (WALCL) stands at $6,724.6 billion as of July 1, 2026, down from $6,735.6 billion a week earlier, continuing the gradual drift lower that has been in place since mid June. The policy rate was held at 3.75% at the June 17 decision, unanimously in line with market consensus. More telling, the committee’s own projections for the rest of the year moved higher: the current year rate projection now sits at 3.8%, up from 3.4% previously, while the projection for the following year rose to 3.4% from 3.1%.

New Chair Kevin Warsh, who took over from Powell, has firmly defended the institution’s independence, including after a Supreme Court ruling that Trump cannot immediately fire Governor Lisa Cook. Warsh said the Fed will not be comfortable with an inflation target above 2%, but also stressed that even though inflation expectations have eased somewhat recently, the bank is deliberately committing to no clear direction until the data becomes more decisive.

Regime: neutral after the end of QT in December 2025, in the middle of a leadership transition, with no clear signal on the next move.

1.2 European Central Bank (Euro Area)

The ECB raised rates by 25 basis points at its June 11 meeting, the first increase since 2023. The deposit facility rate rose from 2.00% to 2.25%, and the main refinancing rate from 2.15% to 2.40%. The central bank explicitly stated that the war in the Middle East is amplifying inflationary pressure through higher energy costs and the disruption at Hormuz, and revised its forecasts higher: headline inflation is now expected to reach 3.0% in 2026, up from a prior projection of 2.6%, while core inflation was raised to 2.5% for both years. At the same time, the ECB trimmed its growth forecast slightly, to 0.8% for 2026.

The balance sheet continues its gradual decline, down to €6,117.3 billion as of June 26. Excess liquidity in the system remains essentially unchanged at €2,198.6 billion, confirming that the rate decision alone does not drain reserves the way an active balance sheet runoff would.

Regime: a shift from a wait and watch stance to active tightening through the rate tool, while balance sheet runoff continues in the background.

1.3 Bank of Japan (Japan)

The BoJ raised its short term policy rate by 25 basis points to 1.00% at the June 16 meeting, in a 7 to 1 vote, the highest level since September 1995. The sole dissenter cited greater downside risks to production and employment. In its policy statement, the board warned that underlying inflation could accelerate above the 2% target because of rising energy costs, and pledged to keep raising rates as warranted while monitoring the impact of the Middle East conflict.

The balance sheet edged slightly higher to ¥664.4 trillion in May because of stabilization operations in the government bond market. But the monetary base continues to contract at an accelerating pace, down 13.70% year on year as of June, deepening from minus 12.20% previously, confirming that the official QT stance is genuinely intensifying. The yen remains weak, with USD/JPY at 161.1, a notable signal given the real rate hike.

Regime: a shift from officially tightening but inconsistently executed policy toward active normalization, driven directly by the inflation risk from the conflict.

1.4 People’s Bank of China (PBoC)

The PBoC held its key lending rates at record lows for a thirteenth straight month in June: the one year LPR remains at 3.00%, the five year at 3.50%. The decision reflects caution over the fallout from the Middle East conflict, even as growth momentum has recently sputtered amid mixed data. Retail sales unexpectedly fell in May, the first decline since December 2022, while industrial output growth accelerated.

The balance sheet continues to shrink, down to CNY 483.8 hundred billion in May. More tellingly, actual liquidity injections are declining meaningfully: MLF injections fell to CNY 500 billion from CNY 600 billion, while reverse repo injections collapsed to just CNY 63 billion from CNY 288.5 billion, a drop of roughly 78%. In early July the PBoC confirmed it had bought only CNY 10 billion of government bonds net in June, a sharp pullback from CNY 50 billion in May and the lowest monthly total since October 2025, aimed at limiting further declines in yields and discouraging speculative excess.

Regime: the only central bank still in easing mode, but with a visibly slowing pace of real injections.

Block 2: Money and Credit Transmission

2.1 United States

M2 hit a new record of $23.05 trillion as of May 2026, up from $22.80 trillion in April, continuing an accelerating trend. C&I Loans (the official BUSLOANS series from FRED) reached $2,885.9 billion in May, up from $2,860.0 billion in April, a rise of nearly 8% year on year, a marked acceleration from the pace seen in prior editions. Total bank system assets showed their first slight decline after a string of records, dropping to $25,447.9 billion. Consumer sentiment is recovering from its historic low in May, while retail sales jumped to 6.90% year on year.

2.2 Euro Area

M3 returned to growth and set a new record of €17,552.2 billion in May, following the temporary decline noted in the prior month. More significantly, corporate credit accelerated for a second straight month, to 4.0% year on year from 3.4% previously, right as the ECB actually raised rates. Household credit continues to accelerate gradually, to 3.10% from 3.00%.

2.3 China

M2 is growing at 8.6% year on year, a stable pace versus the prior month, but the month on month change is minimal, only around 0.18%, suggesting the annual figure largely reflects a base effect rather than fresh monetary expansion right now. Household loans continue to decline. Total Social Financing partially recovered to CNY 2.03 trillion in May, following April’s collapse to CNY 620 billion, but remains well below March’s level of CNY 5.23 trillion.

2.4 Japan

M2 and M3 both hit new records. Bank lending accelerated to 5.7% year on year, the fastest pace since March 2021, led primarily by major banks, whose lending is growing at 8.7%. The contrast with the monetary base, contracting at an accelerating minus 13.70%, remains the sharpest divergence anywhere in this edition.

Block 3: Net Financial Liquidity and Its Relationship to M2

Net Fed Liquidity (NFL), calculated as the Fed’s balance sheet minus the TGA minus RRP, stands at $5.843 trillion as of July 1, 2026. The indicator has moved out of the active recovery regime seen after the tax season in the prior edition, and since late May has been trading in a narrow band between roughly $5.81 and $5.90 trillion, with no clear direction. The TGA continues to draw down, to $880.2 billion from its June peak of $918.7 billion, confirming the expected seasonal effect. RRP remains essentially exhausted, with recurring technical spikes around each quarter end.

The gap between M2 and NFL keeps widening. While NFL sits still, M2 keeps growing and hitting new records every month. That means bank credit and the fiscal deficit, not the federal balance sheet, are carrying the weight of monetary expansion right now.

Read more

INTRODUCTION

Last month, this series traced how the relationship between stocks and bonds shifts with the macro regime, and how the return of an inflationary environment after 2022 revived a correlation pattern not seen since before 1997. That piece was about the price of risk. This one is about the price of money itself, and about a second, quieter consequence of the same regime shift: what happens to government debt when the cost of servicing it rises faster than the economy that has to pay for it.

The relationship is not complicated. It is, in fact, one of the few genuinely mechanical relationships in all of macroeconomics. When the interest rate a government pays on its debt exceeds the nominal growth rate of its economy, the debt-to-GDP ratio rises automatically, even if the budget is balanced. When growth exceeds the interest rate, the ratio can fall even with a moderate deficit. Economists shorthand this as r minus g. It looks like a footnote. It is not. It has, at different points in modern history, forced governments into default, into austerity, or into a third and far more common path: financial repression, the deliberate, sustained suppression of the return on government debt below the rate of growth or inflation.

The United States is now back on the wrong side of that equation, at a debt level that makes the choice unavoidable. This piece asks the question the May parallel did not: when r exceeds g for long enough, what does a government actually do about it, and has it ever been able to do so while inflation, not deflation, was the problem.

THE ARITHMETIC OF r AND g

Start with the identity itself, because everything that follows depends on it holding. Let d be the debt-to-GDP ratio, r the effective interest rate paid on that debt, g the nominal growth rate of the economy, and pb the primary balance as a share of GDP, meaning the budget balance excluding interest payments, with a surplus entered as a positive number. The change in the debt ratio from one year to the next is approximately:

Delta d = (r - g) x d - pb

The logic of the formula is worth sitting with rather than skimming past, because it is the entire argument in one line. The first term, (r minus g) times d, is the automatic, mechanical drift of the debt ratio that happens with no policy decision at all. It is simply the existing debt compounding at the interest rate while the denominator, GDP, grows at a different rate. The second term, pb, is the only lever a government directly controls in any given year: how much it raises in taxes relative to how much it spends, excluding interest.

Run the numbers for the United States as they stand today. The Congressional Budget Office’s February 2026 baseline puts federal debt held by the public at 101 percent of GDP for fiscal year 2026, with net interest outlays of just over 1 trillion dollars, equivalent to roughly 3.3 percent of GDP, against a primary deficit, that is, the deficit before interest costs, of 2.6 percent of GDP.

CBO’s own projections embed a 10-year Treasury rate averaging 4.1 percent this year, rising toward 4.4 percent by 2031, against projected real GDP growth slowing from 2.4 percent in 2026 to 1.8 percent over the following decade. Add CBO’s inflation assumptions and nominal growth lands in the 4.0 to 4.5 percent range for most of the projection window, meaning the effective interest rate on the debt and the nominal growth rate are now close to each other, with the gap easily turning positive in any year financing costs tick up faster than growth, exactly the dynamic the Brookings Institution’s most recent fiscal outlook update describes as a widening gap between the average nominal interest rate on government debt and the nominal growth rate, a gap they explicitly flag as capable of producing explosive debt dynamics.

Plug rough figures into the identity to see the mechanism, not as forecasting, simply as arithmetic. Take d at 100 percent, r at 4.2 percent, g at 4.0 percent, so r minus g equals roughly 0.2 percentage points. On a debt ratio of 100 percent of GDP, that alone adds about 0.2 percentage points to the debt ratio with zero new deficit spending. It looks trivial. It is not, for two reasons. First, the actual primary balance is not zero. CBO puts it at a deficit of roughly 2.1 to 2.6 percent of GDP across the projection window, not a surplus, which is the second term in the formula working in the same direction as the first, not against it. Second, and more importantly, the gap is not fixed. CBO’s own baseline has interest costs roughly doubling in nominal dollars from 1.0 trillion in 2026 to 2.1 trillion by 2036, even as growth assumptions stay roughly flat, which is precisely a widening, not a stable, r minus g.

The result, in CBO’s own central projection and without assuming any crisis, recession, or policy error: debt held by the public rises from 101 percent of GDP in 2026 to 120 percent by 2036, surpassing the previous all-time high of 106 percent of GDP reached in 1946. That figure deserves to be read twice. The United States is on a path, under current law and current baseline growth assumptions, to exceed its post-World War II debt peak within the next decade, not because of a new war or a new pandemic, but because of the ordinary arithmetic of r and g compounding against a primary deficit that does not close.

Source: Congressional Budget Office, The Budget and Economic Outlook: 2026 to 2036, February 2026; Brookings Institution, An Update on the Federal Budget Outlook, March 2026.

TWO PATHS OUT, AND WHY ONE OF THEM IS POLITICALLY DEAD

There are, in principle, only a small number of ways a government can stop d from rising once r exceeds g. It can run a primary surplus large enough to offset the (r minus g) times d term every year, which is fiscal consolidation in its purest form. It can grow the economy faster than the interest rate, which is not a policy choice so much as a hope. It can default or restructure, explicitly breaking the promise to creditors. Or it can change r itself, pulling the interest rate the government actually pays below what an unconstrained market would charge, a deliberate and sustained policy choice known as financial repression.

The first option, fiscal consolidation, is the textbook answer and the one a clean macro model would recommend. It is also, for the United States in 2026, very close to fantasy. CBO’s own baseline assumes the deficit averages 6.1 percent of GDP over the next decade against a 50-year historical average of 3.8 percent, with the major drivers, Social Security, Medicare, and net interest, all structurally rising rather than falling. None of those three is politically available to cut at the scale required without a level of bipartisan agreement that has not existed in Washington for a generation. The arithmetic answer and the political answer to the same question have simply diverged.

That leaves financial repression as the historically dominant response, not because it is elegant, but because it is the only path that does not require an explicit, visible political decision. Default and restructuring are catastrophic and immediately visible to every creditor in the world. Consolidation requires Congress to do something it has shown no appetite for. Repression, by contrast, can be implemented gradually, through regulation rather than legislation, and dressed up as financial stability policy rather than debt management. It is the path of least political resistance, which is exactly why it has been the most common historical response to a debt overhang.

THE ORIGINAL TEMPLATE: THE UNITED STATES, 1942 TO 1951

The cleanest historical case study is the country’s own, and it happened once before, at a debt level the country is now approaching again. By 1946, U.S. federal debt held by the public reached 106 percent of GDP, the previous all-time record CBO now projects will be exceeded again around 2030. Paying that debt down through taxation or spending cuts alone, in the middle of postwar reconstruction with a public exhausted by twelve years of depression and war, was understood at the time to be politically impossible.

The Federal Reserve’s answer began in 1942, not 1946. As part of financing the war effort, the Fed agreed to peg the interest rate on short-term Treasury bills at three-eighths of one percent and capped the yield on long-term Treasury bonds at 2.5 percent, committing to buy whatever quantity of government securities was necessary to hold those rates in place. According to research compiled by the Federal Reserve Bank of Richmond, the Fed maintained this peg for nearly a decade, six full years after the war had already ended, only abandoning it with the Treasury-Federal Reserve Accord of March 1951.

What makes the episode directly relevant to the inflationary framing of this series, rather than simply a curiosity about deflation-era policy, is what happened to inflation while the peg was in place. According to the Federal Reserve’s own historical account, consumer price inflation ran at 17.6 percent between June 1946 and June 1947, and reached an annualized rate of 21 percent by February 1951. Research by Eichengreen places average inflation between 1947 and 1951 above 7 percent. The Fed was pegging interest rates near zero while inflation ran into the double digits, for years, not months. This is the historical proof that financial repression and high inflation are not mutually exclusive. The United States has already done precisely this, at home, within living institutional memory.

The result, documented in a 2024 IMF working paper by Julien Acalin and Laurence Ball that explicitly studies this episode through the r-minus-g lens, was that real returns to U.S. government bondholders averaged negative 0.3 percent annually over the 1945 to 1980 period. The IMF’s broader Reinhart-Sbrancia research, cited by the Richmond Fed, found the same mechanism produced far more severe results elsewhere: negative 6.6 percent annual real returns in France and negative 4.6 percent in Italy over the same decades. The debt was not paid down. It was quietly devalued, year after year, transferred from the government’s balance sheet to the saver’s, through an interest rate that was never allowed to compensate for the inflation actually occurring.

The Acalin and Ball paper makes one further point essential to this piece’s argument: economic growth alone is usually credited with shrinking the postwar U.S. debt ratio from 106 percent in 1946 to 23 percent by 1974, and that story is largely wrong. Their counterfactual simulation, removing only the effects of the pre-1951 interest rate peg and the surprise inflation of the late 1940s, finds that debt would have fallen only to 74 percent of GDP by 1974, not 23 percent. In other words, the bulk of what is popularly remembered as growing out of the debt was, mechanically, financial repression and unexpected inflation doing the work that growth gets credit for.

Source: Federal Reserve Bank of Richmond, A Look Back at Financial Repression, 2021; Federal Reserve History, From WWII to the Treasury-Fed Accord; Acalin, J. and Ball, L., Did the U.S. Really Grow Out of Its World War II Debt?, IMF Working Paper, 2024; Eichengreen, B., Deficits and Debt in the Lens of History, PGPF, 2026.

How the peg actually broke

It is worth dwelling briefly on how the 1942-1951 episode ended, because the mechanism of its collapse is instructive for thinking about the limits of any modern equivalent. Treasury, under Secretary John Snyder, fought to keep the peg through 1950 specifically to protect the value of war bonds held by the public, a political commitment as much as an economic one. The Fed, increasingly alarmed at its loss of control over inflation, resisted. The outbreak of the Korean War in June 1950 made the standoff acute: the FOMC wanted to raise rates to contain a fresh inflationary impulse, and Treasury would not let it. By February 1951, with inflation running at an annualized 21 percent and the bond market beginning to behave abnormally as investors started treating bills and bonds as near-perfect substitutes once the peg removed all interest rate risk, the Fed informed Treasury it would no longer hold the line. The Accord that followed in March 1951 is now remembered as the foundational moment of Federal Reserve independence. It is less often remembered as the moment financial repression, in its original American form, was forced to an end not by a policy decision but by a bond market that had simply stopped functioning as a market.

WHY THE SAME PLAYBOOK IS HARDER TO RUN TODAY

The instinct, having read the 1945-1951 history, is to assume the same toolkit is available now. It is not, and the reasons are structural rather than political, which is precisely why they cannot simply be wished away by a sufficiently determined administration.

The first difference is the openness of the capital account. A saver who disliked negative real yields on Treasury bonds in 1945 had very few alternatives. Today, an American saver can move out of Treasuries and into domestic equities, a money market fund, foreign assets, or commodities, in seconds, from a phone. And the foreign governments and institutions that hold a large share of U.S. debt can rotate elsewhere just as easily. Repression depends on a captive holder of the debt, and the holders of U.S. debt, domestic and foreign alike, have never been less captive.

The second is the reserve currency status of the dollar itself, which cuts in a genuinely double-edged way. It is precisely the dollar’s reserve role that allows the United States to run deficits and accumulate debt that would be unaffordable for almost any other economy, since foreign demand for dollar assets keeps financing costs lower than the fiscal position alone would justify. But that same status makes aggressive, visible repression self-defeating: capital controls or an explicit return to rate pegging in the world’s reserve currency would directly threaten the very demand that subsidizes the debt in the first place. The instrument that makes the debt sustainable is also the instrument a heavy-handed repression strategy would put at risk.

The third is institutional memory, and it cuts directly against the element of surprise that made the postwar episode work. Acalin and Ball’s research is explicit that part of what reduced the real burden of 1940s debt was unexpected inflation, inflation that materialized after bonds had already been priced and sold at the pegged rate. Today’s bond market has just lived through 2022, an episode in which 10-year Treasury yields moved from roughly 1.5 percent to over 4 percent within twelve months as inflation surprised to the upside. Investors, pension funds, and central banks globally are now alert to exactly this risk in a way the 1940s saver, fresh from over a decade of price stability through the Depression, simply was not. A second surprise is far harder to engineer against a market that now actively prices regime change.

THE QUIET PATH: A REPRESSION WITHOUT A NAME

None of this means the underlying pressure toward repression disappears. It means the form it takes in a globalized, dollar-reserve, post-2022 world looks different from a formal Fed-Treasury rate peg with capital controls bolted on. The more realistic path is what might be called repression without a name: a set of individually defensible regulatory and policy choices that, in combination, push the effective r below what a fully free market would set, without any single step requiring the words “financial repression” to be spoken aloud.

Several of the building blocks for this are already visible or actively under discussion in Washington. Treasury Secretary Scott Bessent has publicly floated recasting the relationship between the Fed and Treasury along lines closer to the Bank of England model, including changes to the supplementary leverage ratio that, by Bessent’s own estimate, could lower Treasury bill yields by 30 to 70 basis points simply by making it cheaper for banks to hold government debt on their balance sheets. That is not a rate peg. It is a regulatory lever that produces a similar directional effect, lower yields than an unconstrained market would otherwise demand, while remaining entirely within the language of bank capital regulation.

A second building block is the toleration of inflation modestly and persistently above the Fed’s stated 2 percent target, without any formal change to the target itself. CBO’s own baseline already embeds 10-year Treasury yields and nominal growth converging in a band where r minus g hovers close to zero rather than comfortably negative, meaning even a small additional tolerance for above-target inflation, absorbed quietly rather than announced, does meaningful work on the debt ratio over a decade through the same mechanism the 1940s used, just at a far gentler intensity.

A third is the steady expansion of regulatory and quasi-regulatory demand for government debt: bank liquidity requirements, insurance company capital rules, and pension fund mandates that favor government securities over alternatives. None of these requires legislation in the way a formal capital control would. Each is defensible on its own terms as prudential regulation. Together, they perform a softened version of the same function the postwar peg performed directly: manufacturing a buyer base for government debt that is less price-sensitive than the open market would otherwise be.

Reading the regime shift directly off the data

The mechanism becomes visible in the spread between the 10-year Treasury yield and nominal GDP growth itself, the cleanest real-time proxy for r minus g available without waiting for CBO’s annual projections, and the correct maturity to use rather than the short end, since it is the long end of the curve that the 1942-1951 peg targeted directly and the long end that determines the actual cost of financing a multi-decade debt stock. The series stretches back to 1954 and its shape is, on its own, close to a visual summary of this entire piece. The three regimes described earlier in this piece are visible without any further commentary needed: the spread ran persistently negative, meaning the 10-year yield sat below nominal GDP growth, through most of the 1950s and 1960s, then spiked into deeply positive territory through the inflationary 1965-1981 period, the spread itself touching a peak above 16 percentage points around 1981 as nominal growth collapsed beneath a 10-year yield that had reached roughly 15.7 percent at the Volcker extreme, then spent most of the 1982-2021 disinflationary era oscillating around or modestly above zero, a far gentler and more sporadic version of r exceeding g than the 1970s, before collapsing to roughly negative 10 percentage points during the 2021 inflation surge, when nominal growth briefly ran far ahead of a Fed still holding rates near zero.

That collapse was the disinflationary-era regime in its most extreme form, real growth and inflation both spiking while the Fed had not yet begun to respond, the mirror image of financial repression achieved entirely by policy lag rather than by design. The reversal that followed was equally violent: by late 2022 the spread had snapped back through zero and briefly spiked above 7 percent as the Fed’s tightening cycle caught up with and then overshot the moderating growth rate, before settling into the range the series has occupied since 2023, broadly between 1.5 and 2.5 percentage points. As of the most recent reading, the 10-year spread sits at 1.667 percent, modestly positive, well off the 2022 extreme but still firmly on the wrong side of the line this piece has been describing throughout: r above g, meaning the debt ratio continues to drift upward from this mechanism alone, just at a far gentler pace than during the tightening cycle itself. The chart is not a forecast. It is a real-time read on which side of the r-minus-g line the system currently sits, and as of today it sits, modestly but persistently, on the wrong side.

Source: LiquidityDesk, TradingView.com, US10Y minus USGDPYY, monthly, 1954 to present.

FINANCIAL REPRESSION ACROSS REGIMES

Source: Richmond Fed; Federal Reserve History; Acalin and Ball (IMF, 2024); Reinhart and Sbrancia, as cited by Richmond Fed.

WHAT WOULD MAKE IT FAIL: THE CAPITAL CONTROL QUESTION

The honest version of this argument has to confront its own weakest link directly, because it is the question every careful reader will ask. If quiet, regulatory-style repression is the realistic path rather than a formal 1940s-style peg, what happens if inflation runs hot enough, for long enough, that quiet measures are not sufficient, and savers begin to exit government debt at a pace regulation alone cannot offset. Historically, that is precisely the point at which governments have reached for capital controls: restrictions on the ability to move money out of the domestic financial system, deployed specifically to trap the savings that repression needs in order to function.

The honest answer is that explicit capital controls in a G7, dollar-reserve economy remain a low-probability outcome, not because the fiscal pressure described in this piece is not real, but because the cost of deploying that tool would very plausibly exceed the benefit. A capital control regime in the United States would be a direct assault on the reserve currency status that is simultaneously the only reason the current debt load is financeable on favorable terms in the first place. It is difficult to imagine a policy more likely to accelerate exactly the loss of confidence the repression strategy is designed to prevent.

What is more plausible, and worth watching for as a leading indicator rather than dismissing, is repression’s softer cousins: expanded reporting requirements on foreign holdings, tax treatment that favors domestic Treasury holdings over foreign alternatives, or moral suasion directed at large domestic asset managers and pension funds to maintain or increase government bond allocations. None of these is a capital control in the formal sense. All of them push in the same direction. The distinction between regulation and control is, in practice, a matter of degree, and the history in this piece suggests the degree tends to increase gradually, under fiscal pressure, rather than arriving all at once.

FINAL THESIS

The May parallel in this series argued that the relationship between stocks and bonds is not a law of nature but the product of a specific macro regime, and that the regime appears to be shifting back toward the inflationary logic that prevailed before 1997. This piece extends that argument one layer deeper, into the mechanics of the debt itself. A return to an inflationary regime does not simply change how a 60/40 portfolio behaves. It changes the incentives facing the government that issues the bonds in that portfolio.

When r exceeds g, as it now modestly does, the debt-to-GDP ratio rises mechanically, with or without a new dollar of deficit spending, and the United States is on a baseline path, by its own official projections, to exceed its post-World War II debt peak within the next decade. History offers exactly one example of how a modern, developed government with a debt load of comparable scale resolved that arithmetic without default or true austerity: it suppressed the interest rate it paid, for nearly a decade, through a period when inflation ran into the double digits, and it transferred the resulting cost quietly, through negative real returns, onto the savers who held its bonds.

The instruments available today are not identical to 1942. Capital is more mobile, the dollar’s reserve status cuts both ways, and the market has institutional memory the 1940s saver did not. But the underlying arithmetic has not changed, and neither has the basic menu of options available to any government facing it: consolidate, grow out of it, default, or repress. The first is politically unavailable at the scale required. The second is a hope, not a strategy. The third remains, for a reserve currency issuer, close to unthinkable. That leaves the fourth, arriving this time not as a peg announced on a single day in 1942, but as a slow accumulation of individually reasonable decisions that, added together, do the same arithmetic work.

The question for an investor is not whether this happens, in some dramatic, announced form. It almost certainly will not. The question is whether the portfolio is positioned for a decade in which the real return on holding government debt is quietly, persistently suppressed, the way it was the last time the United States stood where it stands today.

SOURCES

Congressional Budget Office: The Budget and Economic Outlook: 2026 to 2036, February 2026 Brookings Institution: An Update on the Federal Budget Outlook, March 2026 Peter G. Peterson Foundation: National Debt Outlook Gets Worse as Interest Costs Exceed $1 Trillion Annually, April 2026 Peter G. Peterson Foundation: Monthly Interest Tracker, Interest Costs on the National Debt Baker Institute: Key Economic Shifts in the Congressional Budget Office Outlook, March 2026 Federal Reserve Bank of Richmond: A Look Back at Financial Repression, Econ Focus, 2021 Federal Reserve History: From WWII to the Treasury-Fed Accord Federal Reserve History: The Treasury-Fed Accord Acalin, J. and Ball, L.: Did the U.S. Really Grow Out of Its World War II Debt?, IMF Working Paper No. 2024/005 Eichengreen, B.: Deficits and Debt in the Lens of History, Peter G. Peterson Foundation, 2026 Federal Reserve Bank of Richmond: Federal Reserve Independence, Is It Time for a New Treasury-Fed Accord? LegalClarity: What Is Financial Repression and How Does It Work, 2026

liquiditydesk.org | Free Content, Share Freely

Credit markets closed the week in a more cautious mood than last Friday. The signals did not break, but they bent in the same direction across several layers simultaneously. What moved, what it signals, and what to watch next week: full breakdown below for paid subscribers.

Read more

A note on this month’s format. Sector Deep Dive is Liquidity Desk’s monthly format where, instead of tracking the entire map, we focus on one sector in depth. Not just prices and charts, but structure, logic, and why it matters right now. This month we chose the European banking sector. The instrument we will use as our lens is the iShares STOXX Europe 600 Banks UCITS ETF, ticker EXV1, traded on Deutsche Börse Xetra. But before we examine the ETF and the companies within it, we need to understand what this industry actually is, how it is built, and why it is different from everything we know from the American model.

I. A Different Architecture

In America, if a large company wants $500 million, it goes to the bond market. It hires an investment bank, structures an issuance, sells to funds and institutional investors. The bank takes its fee and exits the equation. The company owes the money directly to the market.

In Europe, it walks into a bank.

This is not a detail. It is a fundamental architectural difference between the two economies. In the United States, corporate financing is roughly 70% capital markets and 30% banks. In Europe, the proportion is almost exactly reversed: around 70% flows through bank credit. Every factory, every warehouse, every acquisition, every infrastructure project is, for the most part, financed through a bank loan.

The consequences of this difference are deep and not immediately obvious.

When a company finances itself from the market, the money comes from thousands of different bondholders. If the business runs into trouble, it can negotiate with them separately, buy back the debt at a discount, announce a restructuring. It is unpleasant, expensive, and public, but it is manageable. When it finances itself from a bank, it negotiates with one creditor and follows its terms.

But when those terms are violated, the mechanism activates. And here the difference from the bond market is absolute.

There is no grace period at the borrower’s discretion. There are no anonymous holders to negotiate with separately. The bank is a single creditor, with complete information about you, with rights defined in the contract, and with lobbying and legal power accumulated over decades. When the violation occurs, the bank guards all the doors. And the doors are already closed.

“They guard all the doors, they hold all the keys.”
“Everyone who has fought an Agent has died.”
- Morpheus, The Matrix

Not out of malice, but out of architecture. They are embedded so deeply in the economic fabric of the continent that an alternative practically does not exist for most participants. And almost everyone who has stood against European banks with enough at stake has lost.

II. The Anatomy of the European Bank

The American model knows specialization. There are investment banks, commercial banks, and a distinction between them that historically derives from the Glass-Steagall Act of 1933, a law passed after the Great Depression specifically to separate speculative from deposit banking. The law was repealed in the late 1990s, but the division in thinking, and to some extent in operations, remained.

In Europe, the universal banking model prevails.

One and the same institution takes deposits from households, lends to small businesses, finances corporate acquisitions, trades bonds, manages assets, and offers insurance. Everything under one roof, under one regulatory license, with one balance sheet. BNP Paribas, UniCredit, ING, Barclays - each of them is a financial conglomerate, not a specialized institution.

This gives three competitive advantages.

Depth of relationship. The bank knows the client from the inside. It knows the cash flows, the seasonality, when payments arrive and when stress accumulates. This is an informational advantage the bond market cannot replicate.

Cross-subsidization. If the mortgage business is less profitable this year, investment banking can compensate. Revenue diversification is built into the model.

Regulatory density. Any new bank wanting to enter the market must obtain a banking license, build regulatory capital, pass ECB supervision. The barrier to entry is exceptionally high. Fintech companies spent the last decade trying to disrupt banking. Most ended up buying a banking license or lining up alongside the banks, not against them.

The top 20 holdings in EXV1 illustrate this structure clearly. Only 82 companies form the entire index. Within the 600 stocks of the STOXX Europe 600, the banking sector is concentrated.

For most of their history, banks were defined by physical presence. Heavy doors, imposing buildings, local branches. The product was inseparable from the infrastructure delivering it. A bank in Frankfurt could not serve a client in Lyon without a branch in Lyon. Scale required stone.

That model is gone.

Today a European bank fits in your pocket. ING launched a fully digital bank. BBVA rebuilt its entire technology stack from scratch. Santander completed the migration of its entire technology infrastructure in Mexico to Gravity, its global cloud-based platform, becoming the first systemic bank in the country to operate fully in the cloud. Alongside that, Openbank, Santander's digital-first banking subsidiary, surpassed one million customers in Mexico within a single year of launch. The distribution of the product has been completely transformed: what once required a network of buildings now requires a network of servers.

The implications go further than convenience. When distribution becomes digital, the economics of scale change fundamentally. A traditional branch network had high fixed costs and limited reach. A mobile platform has near-zero marginal cost per additional user. The more customers use it, the cheaper it becomes to serve each one. This is the logic of software, not banking, and it is precisely the logic European banks have spent the last decade importing into their model.

Artificial intelligence is accelerating this shift. Credit scoring, fraud detection, customer service, document processing, regulatory compliance, functions that once required thousands of employees are being automated at scale. Santander Group has committed to generating one billion euros from AI initiatives before 2028, targeting a reduction in its efficiency ratio from 45.3% toward approximately 36% through automation and digital process redesign. The cost structure of banking is moving. Not overnight, and not without friction, but directionally, clearly, and irreversibly.

The result is a business that increasingly resembles SaaS more than traditional financial services. High switching costs, recurring revenue, network effects, and a marginal cost of delivery that approaches zero. The agents have not just guarded the doors. They have rebuilt the doors entirely, and now they are everywhere at once.

III. The Rate Revolution and Its Second Act

To understand why EXV1 has risen 202% over five years, we need to understand one simple but powerful mechanism: the Net Interest Margin, or NIM.

A bank borrows money at one interest rate from depositors or from the central bank and lends it at a higher one. The difference is the NIM. The entire business model of traditional banking revolves around that spread.

Between 2014 and 2022, the ECB kept its deposit rate negative. Banks were paying the central bank itself to park their reserves there. The NIM was crushed. Interest income was minimal. European banks survived mainly on fees and asset management. It was a decade of survival.

In July 2022, the ECB made its historic reversal. Rates moved higher for the first time in eleven years. By September 2023, the deposit rate had reached 4.00%. Then came the reversal cycle: eight consecutive cuts between June 2024 and June 2025, bringing the rate back down to 2.00%. Markets began to wonder whether the banks’ gains from the rate cycle had exhausted their potential.

Then came June 2026.

On June 11, the ECB raised all three key interest rates by 25 basis points. The deposit rate returned to 2.25%. The first rate increase in three years. A reversal of the cycle driven not by an overheating economy, but by something harder to control: the war in the Middle East and its effect on energy prices.

Inflation in the eurozone stands at 3.2%, quite above the ECB’s target. Core inflation, which excludes energy and food and is harder to contain, rose from 2.2% to 2.5% in just one month, between April and May. The energy shock has already fed through into goods and services. The ECB projects inflation of 3.0% for 2026 and 2.3% for 2027. The 2.0% target is not expected until 2028.

Markets are pricing in roughly a 50% probability of another hike in September. Which means: this is not an isolated reaction to one event. This is the beginning of a new tightening cycle.

For European banks, this is a two-sided signal. In the short term, a higher NIM means a wider interest margin and higher lending income. In the longer term, more expensive credit strains portfolio quality: households and companies that borrowed at 2% are now servicing that debt at 2.25%, and likely at more before the year is out. History shows that in every rate cycle, banks first gain from the margin, and then feel the credit losses. Europe is in the first phase.

This is why EXV1 is up 56% over one year and 202% over five. Not because banks became smarter. Because the environment in which they operate changed fundamentally and is now changing again, in their direction.

IV. EXV1: The Instrument

The iShares STOXX Europe 600 Banks UCITS ETF is managed by BlackRock through the iShares division. The fund tracks the STOXX Europe 600 Banks (Capped) Index, covering banking companies within the broad European STOXX 600 index, with a cap on individual position weights. Inception date: April 25, 2001. The fund has survived the dot-com crash, the 2008 financial crisis, the European debt crisis of 2010-2012, COVID, and the current rate cycle. Average annual return since inception: 9.10%.

Something important about the fund’s structure: despite the name “Europe 600 Banks,” HSBC is a British bank whose core business is in Asia and occupies 14.21% of the portfolio. Santander, a Spanish bank with a vast Latin American footprint, is second at 8.68%. This means the buyer of EXV1 does not get pure European continental banking exposure. They get something more complex: European-headquartered banks with global reach.

This is both a risk nuance and a source of potential. HSBC carries exposure to the Chinese and Hong Kong economy in a way that UniCredit or ING does not. Santander carries Brazilian and Mexican risk. When analyzing EXV1, you cannot think only about Europe. You have to think about a global balance sheet, managed by European institutions.

V. The Geopolitical Function

This is the part most analyses miss.

Europe is undergoing a structural transformation not seen since the end of the Cold War. Three parallel processes are happening simultaneously.

Re-industrialization. A consequence of the pandemic, the war in Ukraine, and the recognition of strategic dependency, Europe is investing in manufacturing capacity on its own territory. Chip factories, battery plants, defense industry, pharmaceutical production. Every single one of these investments requires bank financing: long-term project credit, structured by a European bank, with European regulatory approval.

Defense spending. NATO members are pushing budgets toward 2% of GDP, and some significantly beyond. Germany approved a special defense fund of 100 billion euros. Europe as a whole is discussing between 800 billion and one trillion euros in defense investment over the next decade. Where does that money come from? Partly from budgets. Partly from bonds. Partly from bank credit to the companies building the systems.

The energy transition. Offshore wind farms, hydrogen, grid infrastructure. Germany alone has committed tens of billions to energy network renovation. Banks structure these projects, take on syndicated loans, manage the hedging.

European banks are not merely processing transactions. Right now, they are the credit mechanism of Europe’s strategic transformation.

And here we return to the agents. When we talk about the banking lobby in Europe, we are talking about institutions whose history is intertwined with the history of the states themselves. Deutsche Bank is older than unified Germany. BNP Paribas is the product of mergers with roots in the 19th century. Barclays financed British imperialism. Santander grew alongside the Spanish economy after Franco. These institutions do not merely have lobbying power, they are embedded in the political, legal, and regulatory fabric of their countries in a way that leaves no clear boundary between “bank” and “economic system.”

The regulators supervising the banks are former bankers. The bankers running the institutions are former regulators. The door revolves.

This is not a criticism. It is a description of reality that the investor needs to understand. When you buy EXV1, you are not simply buying shares in financial companies. You are buying a stake in the system that manages the credit flow of an entire continent. The system where, if it stops working, nothing else works either.

VI. The Risks

Honesty requires saying this too.

Basel IV and capital requirements. The regulatory framework for bank capital adequacy, known as Basel IV, is being phased in through 2030. The new rules require banks to hold more capital against certain asset categories, particularly mortgage portfolios and operational risk. The effect is two-sided: on one hand, banks become more stable. On the other, less capital is available for dividends and share buybacks. The transition period is manageable, but not insignificant.

Credit portfolio quality. As interest rates rise, corporate and mortgage loans become harder to service. Europe has not yet experienced a significant rise in Non-Performing Loans (NPLs), but with continued rate pressure on households and businesses, the risk is there. Particularly at banks with large mortgage books in markets like Sweden or the Netherlands, where property prices are sensitive to the rate cycle.

Geopolitical tail risk. EXV1 includes HSBC at 14% weight and Santander at nearly 9%. HSBC carries China. Santander carries Latin America. These are not European risks, they are global risks hidden inside a “European” ETF. In the event of escalation around Taiwan, or destabilization of the Brazilian economy, EXV1 will feel the effects, even though the investor believed they had purchased European banking exposure.

The pace of the rate cycle. The new tightening cycle launched by the ECB carries two-sided risk. If inflation proves more persistent than projected and the ECB hikes more aggressively, credit losses will arrive sooner and more painfully. If the Middle East conflict de-escalates quickly and energy prices fall, the ECB may stop the cycle prematurely and the banks’ NIM will compress before reaching its full potential.

VII. The Bottom Line

European banks are not a sexy investment. Nobody talks about them the way they talk about NVIDIA or Tesla. They carry no revolutionary technology, they promise no tenfold returns. They do something more prosaic and more durable: they are the pipeline of the European economy, and the pipeline does not stop working.

A P/E of 11.14 against a historical sector average of 12-13 shows the market is still not fully convinced. A dividend yield of 3.33% in a new rate cycle makes EXV1 interesting for the income-seeking investor.

But more important than the numbers is the context. Europe is in the middle of a decade of re-industrialization, military revival, and energy transformation. All of it flows through bank credit. The agents are everywhere, not because they chose to be, but because the architecture of the continent requires it.

The investor buying EXV1 is not betting on innovation. They are betting on infrastructure. And in Europe, infrastructure has never gone out of fashion.

Liquidity Desk | Sector Deep Dive | June 2026

Read more

Central Thesis

Last night Trump posted on Truth Social: "The deal with the Islamic Republic of Iran is now complete. Hormuz will open." Oil markets reacted instantly: WTI fell more than 5% in two days and now stands at $80.78 per barrel. The average price of regular gasoline at American pumps slipped to around $4.07 per gallon per AAA data from June 14, down from the $4.55 peak on May 21. The media is calling it the end of the shock.

Just look at Urea. The price of fertilizers has crashed 33.78% in a single month to $372.50 per ton. Not because Hormuz opened. But because American farmers stopped buying fertilizers three months ago when their margins collapsed. Fewer fertilizers means lower yields. Lower yields mean less grain. And that is precisely why CBOT Wheat stands at $584 after the diplomatic deal, not at $500.

Oil heard the deal. Grain is watching the harvest.

The American Energy Position: From Shock to Deal

From February 28, 2026, when the news of US-Israeli strikes on Iran broke, commodity markets operated in permanent crisis mode. The Strait of Hormuz was effectively closed from March 4. Three and a half months later came the reversal: on June 15, Trump announced the end of the war and the immediate lifting of the naval blockade.

The reaction was symmetrical to the shock. WTI fell from $107-108 at the start of May to $80.78 today. Brent is at $82.98. We are talking about a correction of around 25% in less than six weeks. The NYMEX HO futures contract, officially called NY Harbor Ultra-Low Sulfur Diesel (ULSD) and the pricing benchmark for diesel fuel in America, is at $3.25 per gallon, down nearly 21% in the last month alone. The RBOB Gasoline futures contract on NYMEX stands at $2.95, which is the wholesale price traded on the exchange. The actual price American drivers pay at the pump averages around $4.07 per gallon per AAA data from June 14, down from the $4.55 peak on May 21. The gap between the two figures covers federal and state fuel taxes, distribution costs, and retailer margin.

Markets are skeptical, however. Neither Washington nor Tehran has released the text of the memorandum. The signing ceremony is scheduled for Friday, June 19, in Switzerland. Shipping companies are waiting for independent confirmation before sending tankers through. Sea mines remain in the strait. Gulf producers who shut in output due to lack of storage need weeks to restart. Israel continues military operations in Lebanon independently of the US-Iran framework. It was precisely Lebanese escalation that caused the April ceasefire to collapse.

Physical oil does not flow simply because a document has been signed.

One number in the dashboard moves in the opposite direction: Henry Hub Natural Gas at $3.18 per MMBtu, up 5% for the month. The American domestic gas market is partially isolated from Hormuz, because natural gas cannot easily leave the country without liquefaction at LNG export terminals. But that isolation is shrinking: US LNG export terminals ran at full capacity throughout the crisis, delivering record volumes to Europe and Asia. The more LNG terminals that are built, the tighter the link between Henry Hub and global prices. For now, American households pay far less for heating than their European counterparts. But the structure is changing.

US Commodity Dashboard - June 2026

Three observations from the dashboard. First, the monthly columns are entirely red for energy. The correction is broad and fast. Second, the annual columns for energy are still green: oil is +10%, ULSD/diesel is +29%, gasoline is +29%. The fact that prices fell from May peaks does not mean the shock has disappeared for those who were paying bills in real time. Third, the CRB Index at 469.98 is weighted 41% agriculture and 39% energy, which is why a 22% oil correction translates into only an 8.5% decline in the full index. The agricultural component is holding.

The Transmission Chain: Three Months Later

Channel 1: WTI / Gasoline - The Political Ceiling Fell

The average price of regular gasoline at American pumps is around $4.07 per gallon per AAA data, down from $4.55 on May 21. Trump received the political relief he was looking for: the price is moving down. But the mechanism matters. Gasoline did not become cheaper because physical supply improved. It became cheaper because markets are pricing in the future opening of Hormuz. If the June 19 signing fails, or if Israel strikes Lebanon this week, WTI could be back above $95 within days. All market positions have already been reoriented toward the normalization scenario. Disappointment would be asymmetric and painful.

Channel 2: ULSD / Logistics - The Delayed Echo Still Echoes

The NYMEX HO futures contract, traded under the ticker HO and officially known as NY Harbor Ultra-Low Sulfur Diesel (ULSD), is the pricing benchmark for diesel fuel in America. At $3.25 per gallon it is down from the May peak around $4.30, but still 29% above year-ago levels. Approximately 70% of all goods in the United States are transported by truck. Every truck runs on diesel.

Track the lag. Diesel was expensive from March through the end of May. Transport contracts reflect fuel costs with a 6-to-10-week delay into the Consumer Price Index. The May CPI showed 4.2%, with energy accounting for more than 60% of the monthly increase. The June CPI, published in July, will be the first reading where the visible cheapening of oil starts to push back against embedded logistical inflation. The two forces will meet there.

The Baltic Dry Index at 2,720 points provides useful context. The BDI measures freight rates specifically for dry bulk cargo: grain, iron ore, coal. It does not include oil tankers, which have their own separate indices. The elevated BDI level, still +37.72% year-on-year, tells us that global demand for raw material shipping remains elevated even as the acute oil shock begins to ease.

Channel 3: Urea - The Critical Warning

Urea is a nitrogen fertilizer produced through a two-step industrial process. First, natural gas is converted into ammonia through the Haber-Bosch process, in which atmospheric nitrogen reacts with hydrogen under high temperature and pressure. The ammonia then reacts with carbon dioxide to produce urea in granular form for direct soil application. Because natural gas is the primary feedstock for ammonia production, any rise in gas prices raises fertilizer costs within weeks.

Urea at $372.50 per ton is the number that deserves attention. In the May analysis we set two key levels: $500 as a demand-stabilization floor and $480 as a warning. Reality exceeded both: Urea is down 33.78% in a single month and has fallen more than 50% from its March peak around $750.

The problem is not the price. The problem is the quantity that went into the ground. The farmer who stopped buying fertilizer in March and April cannot take it back. Nitrogen is embedded in yield. Less nitrogen means less protein in the grain, weaker stalks, lower bushels per acre. These consequences appear at harvest, not today. Read the Urea collapse not only as a signal that the shock has passed, but as a leading indicator for weaker harvests in late 2026 and early 2027, with a 3-to-6-month lag.

Channel 4: Biofuels - The Fading Support

In the May analysis we described how EPA mandates for bioethanol and biodiesel placed a floor under corn and soybeans when oil was expensive: at $102 WTI, grain-based biofuels were economically competitive and sustained energy-sector demand. At $80 WTI the picture changes. The price competitiveness of bioethanol narrows. The EPA mandates remain legally binding, preventing a full collapse of biofuel demand. But the incremental demand above the mandated minimum disappears. Corn at $414 and down 13.15% for the month partially reflects this reality.

Wheat Held. Here Is Why It Matters.

Compare the monthly corrections: WTI -22.64%, Gasoline -21.54%, ULSD/Diesel -20.96%. Wheat: -11.92%. Corn: -13.15%. Soybeans: -8.20%. Grain has corrected roughly half as much as oil. If wheat had followed oil proportionally, CBOT Wheat should be around $520. It is at $584. That difference of roughly 64 cents per bushel is the market saying there is something in grain that the oil deal cannot resolve.

That something is the harvest.

The USDA June report, published on June 12, 2026: winter wheat 2026-27 is projected at 1.03 billion bushels, down 27% from last year and the smallest crop since 1965. Hard Red Winter, the Great Plains variety and the backbone of American exports, is down 38% from last year's level. Only 25% of winter wheat is rated good-to-excellent, the weakest reading for this point of the year in recorded history.

The Hormuz deal can put fertilizer back in the stores. It cannot put rain back into Kansas.

Look at the wheat forward curve: July 2026 approximately $584, September 2026 approximately $598, December 2026 approximately $615, March 2027 approximately $629. The curve is in contango, each successive delivery more expensive than the last. The market is pricing more expensive grain in the future not because it expects a new geopolitical crisis, but because it sees the math: 1.03 billion bushels of supply against 960 million bushels of domestic food use alone. The margin is razor-thin.

The CRB Index in Historical Context: Correction or Reversal?

The CRB Index at 469.98 points, weighted 41% agriculture and 39% energy, is below the historical peak of 516.28 reached during the height of the Hormuz crisis, but still 23.70% above year-ago levels. The distinction between a correction within a cycle and a full cycle reversal is fundamental.

In a correction within the cycle, oil falls from $110 to $80 and stabilizes, grain holds on harvest fundamentals, inflation remains moderately elevated. In a full reversal, oil falls to $60-65, grain follows, CRB returns below 400, and inflation normalizes rapidly. The conditions for a full reversal are not in place: the Fed is not hiking aggressively, global demand has not collapsed, and Hormuz is not yet physically open.

The three historical precedents from the May analysis remain valid reference points. The 2008 crash from 470 to below 200 was triggered by a credit collapse, not a geopolitical resolution. The 2022 correction from 330 followed the most aggressive Fed rate hiking cycle since 1980. Today the Fed is holding at 3.50-3.75%. The structural conditions for a full cycle reversal are absent. Base case: CRB consolidates in the 450-480 range while physical Hormuz reopening progresses over July and August.

The Federal Reserve: A New Chair, The Same Dilemma

The FOMC meeting is today and tomorrow, June 16-17, 2026, and is the first chaired by new Federal Reserve Chair Kevin Warsh. Markets expect rates to be held at 3.50-3.75% with over 96% probability.

May CPI came in at 4.2% year-on-year, three times the Fed's 2% target. Energy accounts for a 23.5% year-on-year increase and for more than 60% of the monthly rise. But Core CPI, stripped of food and energy, was only +0.2% month-on-month, below forecast. Underlying inflation has not broken free. Only the energy shock is stretching it.

The May PPI data adds an important dimension. Producer prices rose 6.5% year-on-year in May, the fourth consecutive month of acceleration and the highest reading since November 2022, beating the consensus of 6.4%. PPI Ex Food, Energy and Trade jumped to +0.80% month-on-month, up sharply from +0.50% in April. PPI matters here not as a standalone headline but as a leading indicator: producer prices transmit into consumer prices with a 4-to-8-week lag. Even if oil normalizes after the Hormuz deal, the pipeline of embedded production costs from March through May is already in the system and will continue to feed into June and July CPI readings. If PPI remains at 6-7%, services and manufacturing inflation will persist regardless of what happens to oil.

Warsh inherits the classic supply shock trap. Raising rates to fight 4.2% inflation would hit an economy with rising unemployment at 4.3% and downward-revised GDP. Holding risks inflation expectations becoming unanchored if Hormuz escalates again. The oil deal from yesterday is the best news the Fed has received since the conflict began. If prices normalize, the June CPI published in July could come in below 3.5%, giving Warsh room to hold without political pressure. But only if the agreement holds.

What We Are Watching: July Signposts

Confirming Signals - Scenario A: Grain Decouples from Oil

CBOT Wheat above $600/bu after the June 19 signing: if wheat does not follow oil lower after the official ceremony, the harvest fundamental is the dominant force.

HO/ULSD futures above $3.00/gal: holding above this level confirms that distillate inflation is embedded in transport contracts and continues feeding Services CPI.

Urea stabilizing above $380/ton: any further decline pushes the fertilizer market into historically low territory and embeds a new yield threat into the 2027 crop.

USDA Acreage Report on June 30: a confirmed shift from corn to soybeans driven by lower fertilizer requirements would give corn additional fundamental support and apply further pressure to soybeans.

Warning Signals - Scenario B: Broad Commodity Correction

WTI below $70/bbl: a sharp move through this level would price in full Hormuz reopening, Gulf production restart, and global recessionary slowdown simultaneously. Grain would follow.

Urea below $330/ton: historically extreme territory associated with severe contraction in fertilizer application and planting area reductions for the following season.

Lebanon-Israel escalation after June 19: if Iran suspends Hormuz access in response to a new Israeli operation, markets will react more sharply than in any previous session because all positions are now oriented toward normalization.

The base case remains Scenario A. The diplomatic deal is real, but implementation is slow and uncertain. Grain has its own argument, independent of Hormuz: 27% less wheat than last year, a 38% collapse in Hard Red Winter, Urea down more than 50% from its peak with embedded yield consequences. These numbers are not cancelled by a Truth Social post.

Oil heard the deal. Wheat is watching Kansas.

Next Issue - July Monthly Commodity Snapshot

The July edition will assess whether the physical opening of Hormuz is confirmed or another disappointment. Key questions: Was the June 19 signing confirmed? Is oil actually flowing from the Persian Gulf in meaningful volumes? Does the June CPI, published in July, show the beginning of energy disinflation? And perhaps most importantly: after the Hard Red Winter wheat harvest, do actual yields confirm the worst USDA forecast since 1965?

This publication is for informational and educational purposes only. Nothing herein constitutes investment advice or a solicitation to buy or sell any financial instrument. Past performance is not indicative of future results. Always conduct your own research before making any investment decision.

Weekly Credit Markets Monitor | Liquidity Desk

Credit markets closed the week quietly. Rate volatility continued to ease, and the credit backdrop remained constructive across the indicators we track. Net Fed Liquidity expanded, driven primarily by Treasury dynamics rather than any shift in Fed policy. Full analysis, signal breakdown, and positioning conclusion are available to paid subscribers below.

Read more

In May, markets moved along two parallel tracks. The first was technological: the US-China trade truce opened space for AI capital expenditure, and the sector moved sharply higher. The second was geopolitical: tensions around the Strait of Hormuz pushed oil prices up and drove the energy sector in different directions depending on the region.

In June, neither story disappeared they simply rearranged. Technology remains the leading force, but no longer uniformly across regions. The European Tech ETF (EXV3) is up more than 10% in a single month, while US XLK is up a modest 1.5%. The gap is not coincidental. It reflects where each market started: US Tech had already run far ahead, European Tech was catching up from behind.

Geopolitical tensions around the Middle East have not gone away, but markets are repricing them. US Energy (XLE +5.7%) remains strong, while European Oil & Gas (EXH1 -2.0%) tells a different story one shaped by currency headwinds and a different regulatory environment. The dollar strengthened roughly 1.7% over the month, adding further pressure on emerging markets, particularly in Latin America.

The rotation visible in June is a story about differentiation: not all markets respond the same way to the same global signals. Who is catching up, who has overrun, and who is moving to an entirely different logic that is what this analysis examines in detail.

Macro Context

Rate Environment

The US Federal Reserve holds its effective rate at 3.62%, after a series of cuts from its 2024 peak. Yet the yield on the 10-year US Treasury is moving in the opposite direction: it currently sits at 4.54%, up 0.11% in the past month alone. This divergence between the short-term policy rate and long-term market yields is an important signal the market is betting that inflation and geopolitical pressures will keep borrowing costs elevated for longer, regardless of what the Fed does at the short end.

In Europe, the European Central Bank is expected to raise rates by 0.25 percentage points on Thursday, from 2.15% to 2.40%. Eurozone inflation has reached its highest level in over two and a half years, fuelled by the energy price shock following the Hormuz disruption. The German 10-year Bund yield sits at 3.05%, near an 18-month high, and is up more than 0.5 percentage points over the past year.

The Bank of Japan holds its short-term policy rate unchanged at 0.75% since January. Taken in isolation, Japan looks far behind the other central banks. But that picture is incomplete. The yield on 30-year Japanese Government Bonds (JGBs) is around 3.8%, and the 10-year sits at 2.67%. This is a steeply steepened yield curve: the short end pinned at 0.75% by policy, the long end moving freely higher under the pressure of inflation, fiscal concerns, and expectations of further monetary normalisation. For context: two years ago, the 30-year JGB was below 2%. In the past year alone, the long end has risen by more than one full percentage point one of the sharpest moves in the developed world. The next BOJ meeting is on June 16, with markets pricing in a hike to 1.00% and additional increases expected before year-end. Japan is quietly but irreversibly exiting the era of zero interest rates.

The Broad Dollar

The dollar strengthened approximately 1.7% over the past month, measured by the Federal Reserve’s Broad Dollar Index (DTWEXBGS), which covers around 26 of the United States’ key trading partners. The index currently stands at 120.08, up from 118.10 a month ago.

Dollar strength is a double-edged sword. For US companies with international revenues, it compresses earnings when foreign profits are translated back into dollars. For emerging markets whose debt is denominated in dollars, it means higher servicing costs in local currency terms. Latin America is feeling this directly, which explains much of the selling pressure visible across the region this month.

Risk Appetite

The VIX Index which measures expected volatility in the US equity market and serves as a gauge of investor fear currently stands at 20.77. For context: readings below 20 generally signal calm, above 20 indicate elevated nervousness, and above 30 are associated with active panic. The current level sits precisely at that boundary, and is up more than 17% compared to a year ago. The spike this week from around 17 to above 20 coincides with an escalation in Middle East tensions and stronger-than-expected US employment data, which pushes back the prospect of further Fed rate cuts.

United States Sector Rotation

Looking at the ranking of US sectors over the past month, the first thing you will notice is that the leader is unusual. Health Care (XLV) sits at the top with +7.2% for the month. Not technology. Not energy. Health care.

This is not coincidental, and it is not merely a matter of short-term market logic. The demographic picture across the developed world is unambiguous: ageing populations in the United States, Europe, and Japan mean structurally growing demand for healthcare services, pharmaceuticals, and medical infrastructure over the coming decades. This is one of the few sectors where long-term demand growth is largely predetermined, regardless of the economic cycle. With VIX above 20 and 10-year yields moving higher, this combination of structural growth and relative resilience in an uncertain environment attracts capital. XLV is not a purely defensive sector: it combines stable revenues with an ongoing innovation cycle in biotechnology and medical devices.

Energy (XLE) maintains its strength at +5.7% for the month. Geopolitical tension around the Strait of Hormuz continues to sustain a risk premium in oil prices, and US energy companies benefit directly. Notably, this stands in sharp contrast to European Oil & Gas (EXH1, -2.0%): the same global oil price environment, but a different outcome because currency movements, regulatory frameworks, and the composition of the two ETFs differ substantially.

Financials (XLF) is up 2.4% and holding steady. Banks benefit from a steeper yield curve: they borrow cheaply at the short end and lend at higher rates on the long end. The current shape of the curve is a favourable environment for bank margins.

Technology (XLK) is up just 1.5% for the month, despite a 3-month return of +27.5%. This is not a reversal it is a cooling after an exceptionally strong rally. The sector is not falling; capital is simply looking elsewhere, temporarily.

In negative territory are Consumer Discretionary (XLY, -5.0%) and Communication Services (XLC, -4.3%). Consumer Discretionary is sensitive to both interest rates and inflation simultaneously: more expensive credit compresses household spending, while energy price uncertainty adds further pressure. XLC suffers from a specific mix: advertising budgets are cyclical, and streaming businesses are valued at a higher discount rate in a higher-rate environment.

Materials (XLB, -3.1%) and Industrials (XLI, -1.1%) are under pressure, reflecting weaker global manufacturing data and a strengthening dollar that makes US exports more expensive.

US Sector Performance Monthly Comparison

Summary: Rotation from growth to quality. Health Care and Energy lead; Tech cools after a strong Q1; cyclical sectors under pressure from rates and the dollar.

Europe Sector Rotation

The European picture in June has one dominant signal: technology is catching up, and it is doing so at a pace that cannot be ignored. EXV3, the iShares ETF tracking European technology companies in the STOXX 600, is up more than 10% in a single month. This is not merely a leadership position in the ranking it is a category of its own. The next sector sits roughly seven percentage points behind.

How to explain this? European Tech started from a significantly lower base than its US counterpart. While XLK accumulated 27.5% in the past quarter, EXV3 over the same period returned 23.7% from a much lower starting point. Investors who missed the US technology rally, or who are looking for a lower-valuation entry into the same AI theme, find European Tech a relatively more attractive proposition. Companies like ASML, SAP, and Infineon are the core of EXV3, and each is directly tied to the global semiconductor and AI capital expenditure cycle.

Travel & Leisure (EXV9, +5.0%) is the second leader for the month. European tourism remains structurally robust: the summer season approaches, bookings are at record levels, and the sector benefits from the combination of a relatively weaker euro which makes Europe more attractive to inbound tourists and resilient domestic consumption.

Retail (EXH8, +6.5%) is the surprise of the month. With rising rates and an imminent ECB hike, the consumer sector would normally be under pressure. Here, however, the composition of the ETF likely plays a role: it skews toward specialised and luxury retailers rather than mass-market names.

Banks (EXV1, +1.0%) show modest gains for the month, but context matters: the 3-month return is +10.2% and the 1-year return is +29.4%. European banks are among the structural winners of the higher-rate environment in the eurozone. Thursday’s anticipated ECB hike adds further support to their net interest margins.

In negative territory, Automobiles (EXV5, -2.3%) and Basic Resources (EXV6, -1.7%) stand out. The automotive sector continues to suffer from a combination of competition from Chinese electric vehicle manufacturers, a slow EV transition domestically, and a cyclical softening in demand. Basic Resources pulls back after a strong 6-month rally (+31.2%), which is unsurprising: after a period of outperformance, the sector rests even without a fundamental shift.

Oil & Gas (EXH1, -2.0%) is perhaps the most telling contrast in the entire analysis. At a time when geopolitical tension sends US XLE up 5.7%, the European oil and gas ETF is in negative territory. The reasons are several: dollar strength compresses the revenues of European companies whose output is sold in dollars but whose costs are in euros; regulatory and tax pressure in Europe is heavier; and the current ECB policy stance is less supportive for capital-intensive sectors.

European Sector Performance Selected

Summary: European Tech is the story of June. Beneath the surface: banks continue their structural cycle, tourism holds, while autos and commodities remain under pressure.

Asia Country Rotation

In Asia, sector-level analysis gives way to country-level analysis. The reason is structural: Asian markets differ sufficiently from one another in regulatory environment, currency dynamics, and economic cycle that a country ETF tells more than any sector indicator. An investor in EWY (South Korea) and an investor in FXI (China) are living in entirely different realities, even if both are nominally “invested in Asia.”

Taiwan (EWT, +3.2%) and South Korea (EWY, -4.4%) are the two semiconductor markets in the group, but with different outcomes for the month. EWT holds positive ground while EWY pulls back. The difference is not fundamental but technical: EWY has accumulated +35.8% in just the past quarter and +90.3% over six months one of the strongest moves across the entire ETF universe in this analysis. At that pace, a -4.4% pullback in a single month is more likely a healthy pause than a signal of reversal. Both markets remain structurally tied to the global AI and semiconductor cycle: TSMC dominates EWT, Samsung and SK Hynix dominate EWY.

China is split across two ETFs with different scopes but a single message: FXI, which tracks large-cap Chinese equities, is -6.3% for the month; MCHI, the broader China market, is -6.8%. The 6-month performance of both sits around -10% to -11%. This is not a short-term correction it is continued, sustained weakness. Domestic demand in China remains subdued, deflationary pressure has not been fully resolved, and geopolitical tensions around Taiwan add a risk premium that investors find difficult to price. Dollar strength adds further pressure on the yuan and increases the cost of dollar-denominated debt service.

India (INDA, -4.2%) is the negative surprise. Unlike China, where weakness has clear fundamental explanations, the Indian market pulls back despite a relatively solid macro picture. The 1-year performance is -13.6% significant for a market that a year ago was the favoured alternative to China for many international investors. Likely contributing factors include elevated valuations after the previous period of enthusiasm, a weaker rupee against a strengthening dollar, and partial capital outflows from emerging markets broadly.

Japan (EWJ, -2.7%) gives back modest ground for the month. The context from the Macro Context section is critical here: while the BOJ policy rate sits at 0.75%, 30-year JGB yields are around 3.8%. This steep curve signals that the market is running ahead of the central bank in expecting normalisation. Higher long-term rates in Japan reduce the incentive for the carry trade the practice of borrowing cheaply in yen and investing The partial unwinding of these positions puts pressure on Japanese equities.

Asia Country ETF Performance

Summary: Semiconductor markets retain structural strength despite short-term fluctuations. China remains under sustained pressure. India disappoints. Japan adapts to a new rate reality.

Latin America Country Rotation

Latin America is the weakest region in June without exception. Four of five ETFs are in negative territory for the month, and the broad regional index ILF is down 8.7%. To understand why, the starting point is not the local markets it is the dollar.

The roughly 1.7% strengthening of the broad dollar index over the month is a direct hit to Latin American assets through two channels. First, most of the commodities these economies depend on are priced in dollars: when the dollar rises, commodity revenues in local currency terms shrink relative to expectations. Second, a significant portion of corporate and sovereign debt in the region is dollar-denominated: a stronger dollar means more expensive debt service in local currency.

Brazil (EWZ, -13.5%) is the worst-performing market across the entire universe this month. This is an exceptionally sharp move even for a volatile emerging market. On top of the structural dollar headwind, specific domestic factors compound the pressure: Brazil’s fiscal position remains vulnerable, real interest rates are high, and periodic political uncertainty around budget discipline continues to unsettle international investors. When global risk appetite declines, Brazil is typically among the first markets from which capital exits.

Mexico (EWW, -6.2%) faces an additional specific risk: proximity to the US economy, which is normally an advantage, in the current environment also carries direct exposure to Washington’s trade policy. Uncertainty around tariffs and the future of the USMCA trade agreement adds a risk premium that weighs on valuations.

Chile (ECH, -6.0%) is tied to the copper cycle. With a strengthening dollar and signs of softening Chinese demand, copper is under pressure and that flows directly into Chilean revenues and market valuations.

Argentina (ARGT, +3.3%) is the sole green patch in the region and deserves separate attention. The Milei reform programme continues to attract capital despite and perhaps because of the broader regional weakness. Investors positioned in the Argentina story are doing so on a specific thesis: fiscal consolidation, relaxation of currency controls, and structural economic transformation. That thesis does not depend on the direction of the dollar or general EM sentiment, which explains why Argentina is moving to a different rhythm from its neighbours.

Latin America Country ETF Performance

Summary: LatAm under systemic dollar pressure. Brazil most affected by the combination of global and local risks. Argentina stands apart with a reform story that temporarily insulates it from regional trends.

Rotation Signal & Conclusion

When we place all four regions side by side, one pattern comes into focus: capital is moving toward quality and selective growth, and away from broad bets on cyclicality and emerging markets.

This is not panic. A VIX at 20.77 sits at the edge of nervousness but does not signal active distribution. It is more accurately described as a repositioning: investors are not leaving markets, they are choosing more carefully which ones to stay in.

Three themes dominate the June rotation.

The first is technology as a global theme with regional differentiation. Across the US, Europe, and Asia, the technology sector and its adjacent markets are among the leaders over longer time horizons. But on a monthly basis, the differences are instructive: European Tech (EXV3, +10.8%) is catching up aggressively; the Taiwan market (EWT, +3.2%) holds steady; and US XLK (+1.5%) pauses after an exceptional quarter. The thesis around the AI capital expenditure cycle and semiconductor demand remains intact, but the market is now more selective about the precise point of entry.

The second theme is the geopolitical risk premium in energy but only in specific places. US Energy (XLE, +5.7%) continues to benefit from the Hormuz context. European Oil & Gas (EXH1, -2.0%) does not. This divergence suggests that investors are not buying oil as a global macro theme they are buying specifically US exposure to it, with lower regulatory and currency overhead.

The third theme is the dollar as the regulator of global flows. The 1.7% monthly strengthening is sufficient to explain much of the LatAm weakness, the pressure on the Chinese yuan, and the correction in India. If the dollar continues to strengthen on the back of higher US rates and geopolitical uncertainty, emerging markets will continue to face structural headwinds.

Outside these three themes, Health Care sends a quieter but important signal. When Health Care leads the US ranking in an environment of elevated volatility, the market is telling you it prefers predictability over aggressive growth. Combined with its demographic inevitability, the sector deserves a permanent allocation regardless of where we are in the economic cycle.

The June conclusion is this: global rotation is not unidirectional it is multi-layered. Technology remains the structural theme but is increasingly being traded on a region-by-region basis. Quality and predictability are becoming more valued as uncertainty rises. The dollar is the key variable for emerging markets. And Argentina continues to remind us that sometimes the best story in the room is the one nobody expected.

Thursday evening, Goldman Sachs placed model rockets in the lobby of its Wall Street headquarters. Morgan Stanley was preparing its own event for Monday. JPMorgan gathered over 3,500 clients for a special presentation. The machinery of Wall Street was running at full speed around the SpaceX IPO, a deal valued at $1.75 trillion with a planned raise of $75 billion, which would make it the largest IPO in history.

And right at that moment, S&P Dow Jones Indices said: not so fast.

A Little Background

Before we understand the S&P decision, we need to understand exactly what they were trying to change and why it made sense to do so.

When a company goes public, it does not automatically enter the S&P 500 or Nasdaq-100. Traditionally there is a waiting period: the company must trade for at least twelve months before being considered for index inclusion. The rule exists for a specific reason: to give the market enough time to discover a real price for the stock, without forcing passive capital to buy in from day one.

In early 2026, Nasdaq changed its rules. The new "Fast Entry" regime, effective from May of this year, allows companies in the Top 40 by market capitalization to enter the Nasdaq-100 just 15 trading days after their debut. FTSE Russell followed with similar changes.

SpaceX will list its shares on Nasdaq under the ticker SPCX. With a market capitalization of $1.75 trillion, it would enter the Nasdaq-100 almost immediately. But the S&P 500 is a different story.

Why the S&P 500 Said No

On June 4, 2026, the day before the IPO marketing machine hit full speed, S&P Dow Jones Indices published a press release. The content is simple: the rules remain unchanged.

The twelve-month seasoning period - preserved. The GAAP profitability requirement - preserved. No exceptions based on size or market capitalization.

For SpaceX, the second condition is the fatal one. The company reported a net loss of $4.94 billion in 2025, even as revenue grew 33% to $18.67 billion. S&P requires GAAP profit in the most recent quarter and across the sum of the most recent four quarters. SpaceX meets neither.

In short: even after twelve months pass, SPCX cannot enter the S&P 500 until it shows real accounting profit.

Why Does It Matter Which Index - Isn't a Stock Just a Stock?

This is the part most retail investors do not fully grasp.

The S&P 500 is not just a list of five hundred companies. It is the gravitational center of global passive capital. Index funds and ETFs with over $10 trillion in assets track exactly this benchmark. When a company enters the S&P 500, those funds are obligated to buy it, proportional to its weight. Not because their analysts like it. Not because the valuation is attractive. But because the rule requires it.

That is forced buying in its purest form.

The Nasdaq 100, by contrast, is a smaller club - one hundred companies, focused on the technology sector. QQQ, the main ETF tracking the Nasdaq 100, manages over $300 billion. Also significant, but the S&P 500 is a different scale.

When Nasdaq changed its Fast Entry rules, it opened the door to something specific: companies with enormous market capitalization, a small public float, and still immature financial histories to receive a massive mechanical boost from passive flows almost from the moment of listing.

The S&P 500, with its decision this week, refused to do the same.

Two Worlds

The result is a curious divide.

SPCX will enter the Nasdaq 100 after 15 days. QQQ and all funds tracking the Nasdaq 100 will be obligated to buy it. The mechanical buying will trigger almost immediately after the IPO, at a moment when the public float is artificially small and insiders are locked up for 180 days and cannot sell.

But the S&P 500 will remain closed. The trillions of passive capital tied to that benchmark will not be activated, at least not in the near future.

How the Deal Is Constructed

To understand the full consequences, we need to understand exactly how the mechanics of this IPO are arranged.

SpaceX is not releasing all of its shares to the market. The public float, meaning the shares actually available for purchase on the exchange is artificially small relative to the company's total valuation. Musk and early investors are holding the vast majority. But here is the catch: Nasdaq calculates the weight of SPCX in the index at a multiplier of up to three times the actual float. Meaning the company weighs in the index far more than is actually trading.

Add to that the 180-day lock-up period. Insiders - venture funds, early employees, everyone who entered before the IPO, are legally prohibited from selling shares for the first six months after listing.

Now line up the three elements.

First: passive funds tracking the Nasdaq-100 are obligated to buy SPCX after just 15 days. Not because they want to, because the rule requires it. Hundreds of billions of dollars move mechanically.

Second: supply is limited. Few shares trade publicly, and insiders cannot sell. Limited supply plus forced demand has only one mathematical result - the price rises.

Third: when the lock-up expires after six months, insiders are not selling into a panicked market. They are selling into a market artificially supported by months of forced index buying, with ready buyers, the index funds themselves obligated to absorb the supply in order to maintain the correct portfolio weight.

This is the exit liquidity mechanism. Early investors exit at high prices, financed by the pension funds, ETFs, and index portfolios of ordinary people around the world. Perfectly legal. Perfectly transparent, if you know where to look.

Exit Liquidity - Reduced, Not Eliminated

This mechanism works, but only if all passive doors are open simultaneously.

The Nasdaq 100 door is open. The hundreds of billions in QQQ will activate after 15 days.

But the S&P 500 door remains closed. The ten trillion in passive capital tracking that benchmark will not be activated. Not until SpaceX shows GAAP profit. Which, with a net loss of nearly $5 billion last year, does not look like a next-quarter event.

The exit liquidity mechanism is cut in half. Not zero, but significantly smaller than the scenario where both index giants open their doors simultaneously. Early investors get fewer forced buyers. Less mechanical upward price pressure. A harder exit at the top.

Who Pays for SPCX's Entry Ticket

But the story does not end there. There is another side to the rebalancing that affects people who never thought about buying SpaceX.

When SPCX enters the Nasdaq 100, the index must remain 100%. To make room, all other components are reduced proportionally. QQQ and all funds tracking the Nasdaq 100 are not just buying SPCX, they are simultaneously selling Apple, Microsoft, Nvidia, Meta, and Alphabet. Not because those companies are overvalued. But because the arithmetic of the index requires it.

The effect is amplified by the 3x float multiplier. The larger the artificial weight of SPCX, the greater the mechanical selling from the remaining components.

Those most strongly hit will not be people holding QQQ, for them the effect is partially offset by the purchase of SPCX within the same fund. Those most strongly hit will be investors with direct exposure to Nasdaq 100 components. If you hold Apple, Nvidia, or Microsoft directly as stocks or through a sector ETF like XLK, you receive mechanical downward pressure on prices from the index rebalancing, without having anything to do with SPCX. You have no offsetting position. You simply feel the selling.

And here it is important to understand one thing clearly: the S&P 500 decision not to include SPCX is not protection from this effect. Apple and Nvidia are simultaneously in the Nasdaq 100 and in the S&P 500 with enormous weight. The mechanical selling from the Nasdaq rebalancing is reflected in the prices of the stocks themselves and from there into XLK, into the S&P 500, and into every portfolio that holds those names. The S&P 500 simply refused to add its own forced buyer of SPCX. From the downward pressure on the technology sector, it cannot opt out.

The Bigger Message

Index rules look like technical bureaucracy. They are not.

They determine who gets access to the forced capital of passive investing and who does not. In a world where passive strategies control tens of trillions of dollars, the decision to include or wait is not a neutral action. It is the distribution of enormous capital flows with real consequences for everyone who holds an index fund, a sector ETF, or direct positions in the technology sector.

Nasdaq chose flexibility. S&P chose conservatism. Which approach is better for the long-term market mechanism, that is a question we will answer after the next few cycles.

But for now, SpaceX received only half the doors. The rocket is impressive. The profit.. not yet.

W23 2026 | June 5, 2026

Weekly Credit Markets Monitor | Liquidity Desk

Credit regime this week: RELAXED

Credit markets enter June in relaxed mode. Rate volatility has pulled back from its May spike, short-term funding stress has reversed after three consecutive weeks of increases, and the credit risk premium remains at historically calm levels.

This week's full Credit Pulse covers all five indicators, this week's Net Fed Liquidity breakdown, and the Positioning Conclusion with the current credit regime assessment

Read more

In the last edition, we closed with the image of an open wound in the global economy. The Strait of Hormuz. A disruption that had not ruptured completely but was not healing either. Three weeks later, the answer is: it is still there. But the body is healthy enough, for now, to absorb the damage.

Global liquidity is no longer contracting in unison. Quantitative tightening in the United States ended in December. M2 is at a new record high in almost every major economy. Bank credit is expanding. Credit spreads, the additional compensation investors demand for taking on risk, remain tight. Volatility is contained.

But liquidity is not flowing evenly everywhere. It reaches markets unevenly, concentrates in specific sectors and regions, and depends on conditions that can change. The question is not whether the system is functioning today. The question is how long those conditions hold while the inflammation continues to smolder.

Block 1: Central Banks

1.1 United States - QT Has Stopped, But Inflation Does Not Allow a Clean Easing Cycle

The Federal Reserve held its policy rate at 3.75%. Quantitative tightening, the active withdrawal of liquidity through balance sheet reduction, was stopped in December last year. The balance sheet stands at approximately $6.704 trillion, essentially unchanged week on week.

This is an important shift in regime: the Fed balance sheet is no longer a mechanical source of liquidity drain. But it does not mean a clear path to easing.

CPI accelerated to 3.8% year on year in April, above the consensus of 3.7% and above the prior reading of 3.3%. Core PCE, the measure the Fed monitors most closely, is at 3.3%. These numbers leave the central bank in a waiting mode: it cannot ease because inflation does not permit it, and it cannot tighten because the economy does not require it.

After the end of QT, the short-term driver of system liquidity is no longer the Fed balance sheet but the Treasury General Account (TGA). When the government collects tax revenue and leaves it unspent at the Federal Reserve, those funds leave the banking system. When the government spends, they return. This mechanism explains most of the weekly fluctuations in Net Fed Liquidity and matters more right now than movements in the Fed balance sheet itself.

Net Fed Liquidity stands at $5.872 trillion as of May 27, recovering from the tax season low of $5.594 trillion. The banking system continues to expand, reaching $25.458 trillion in total assets, a new record. Together with rising C&I loans and M2 in the next block, this suggests the domestic credit channel in the United States looks more stable.

The weak link is the consumer. The Michigan Consumer Sentiment index fell to 44.8, a new record low, while inflation expectations are rising. The Fed cannot respond to weak growth alone while price pressures remain elevated.

1.2 Euro Area - ECB Is in a Softer Regime, But the Signal Is Not Clean

The ECB stands in a softer policy position than the Fed: main refinancing rate at approximately 2.15%, deposit facility rate at 2.00%. The balance sheet is around 6.186 trillion euros, slightly up week on week but not a significant new injection. Excess liquidity in the system sits at approximately 2.199 trillion euros, a large buffer that is no longer growing aggressively.

The problem is inflation. Headline came in at 3.5% year on year in May, above the consensus of 3.0%. Services inflation remains persistently elevated. This limits how aggressively the ECB can act even in its softer stance.

Activity data is mixed. Manufacturing PMI is 51.6, still in expansion territory, but services PMI fell to 46.4 and composite PMI is 48.8, a reading below 50 that signals a mild contraction in the broader economy. Europe is growing more slowly than the United States, and the transmission of policy to the real economy remains uneven.

1.3 Japan - BoJ Normalization Remains the Key Regional Risk

The Bank of Japan held its short-term policy rate at 0.75%, but the decision was not unanimous: three board members voted for a hike to 1.0%. Japan is the only one of the four economies in which the direction of travel is upward, not sideways.

Why this matters beyond Japan: decades of near-zero rates made yen-denominated borrowing extremely cheap. Investors worldwide borrowed in yen and deployed that capital into higher-yielding assets elsewhere. If the BoJ continues to normalize, the cost of those positions rises and unwinding them can produce volatility in entirely unrelated markets. For now this is a normalization risk, not a funding accident.

The BoJ balance sheet stands at approximately 663.3 trillion yen, slightly up from 662.1 trillion. The inflation outlook for FY2026 was raised to 2.8% from 1.9%, while the growth forecast was cut to 0.5% from 1.0%. An uncomfortable combination: higher inflation expectations, weaker growth, and pressure to normalize. The 10-year Japanese government bond yield is around 2.74%. The yen remains a key global liquidity variable.

1.4 China - Loose Policy Exists, But Transmission Remains Weak

The People’s Bank of China maintains a moderately loose stance: 1-year Loan Prime Rate at 3.00%, 5-year LPR at 3.50%, reserve requirement ratio for large banks at 7.50%. Policy is supportive but not aggressively reflationary.

The PBoC balance sheet fell to approximately 486,327.5 CNY hundred million in April from 491,398.7 in March. Liquidity injections via reverse repo declined to CNY 11 billion from CNY 123 billion. CPI is 1.2%, a signal of weak domestic demand. PPI is accelerating to 2.8% due to production input costs, a strange combination in which the consumer is not spending but the industrial sector is absorbing price pressure. China is not a source of acute liquidity stress, but it is not a strong global reflation engine either.

Block 1 Conclusion

Global central banks are no longer tightening in unison, but they are not easing in unison either. In the United States, QT has stopped but the Fed is constrained by inflation. In Europe, the ECB is in a softer mode but the data is uneven. In Japan, the BoJ remains a normalization risk. In China, policy is loose but the effect is limited. Liquidity pressure is easing without being replaced by a new synchronized impulse.

Block 2: Money and Credit Transmission

2.1 United States - Broad Money and Bank Credit Are Improving

M2 in the United States rose to $22.805 trillion in April from $22.686 trillion in March, a new record high. Broad money supply is no longer confirming a tightening regime. After the period of QT and liquidity drain, M2 has not only recovered but exceeded its previous peak.

Commercial and industrial loans also rose to $2.865 trillion from $2.822 trillion. When businesses borrow, they typically do so because they see demand ahead of them. Together with the banking system balance sheet at a record $25.458 trillion, the credit channel in the United States is not frozen despite lending rates around 6.75%.

Consumer credit gives a more mixed signal. The $24.86 billion increase in March looks strong on the surface, but the structure matters. Revolving credit (credit cards) rose to $1.34 trillion while nonrevolving credit (auto and student loans) reached $3.90 trillion. Households are using credit to sustain spending. That is different from credit driven by confidence and investment.

2.2 Euro Area - Credit Is Stable, But M3 Cooled for the First Time

In Europe the picture is more uneven. M3 fell to 17.434 trillion euros in April from 17.474 trillion in March. After several months of consecutive increases, April is the first monthly decline. It is not a systemic signal, but it is the first indication that the monetary impulse is losing momentum.

Corporate lending accelerated to 3.4% year on year from 3.2%, above the consensus of 3.1%. Household credit growth held steady at 3.0%. These readings are constructive, but the M3 cooling makes the overall picture more cautious: corporate credit is growing, but broad money is no longer confirming it with the same force.

2.3 China - Credit Creation Is Weak Despite Supportive Policy

Chinese credit transmission remains the weakest among the four regions. Total Social Financing, the broad measure of new financing flowing into the economy, fell to CNY 620 billion in April from CNY 5.23 trillion in March, well below the consensus of CNY 1.5 trillion. This confirms that policy support does not automatically translate into real credit momentum.

Household lending declined and outstanding loan growth slowed to 5.6% year on year from 5.8%. PMI data provides a slightly better signal, with Composite PMI rising to 53.1 and manufacturing PMI at 51.8. Stabilization in activity, but not a change in credit weakness. China remains a stabilization story, not an acceleration story.

2.4 Japan - Money Supply and Bank Lending Remain Supportive

Japan shows perhaps the most interesting contrast in this block. M2 rose to 1,295.4 trillion yen in April from 1,279.5 trillion, and M3 rose to 1,640.5 trillion from 1,625.1 trillion. Bank lending accelerated to 5.4% year on year from 4.8%, above the consensus of 4.6%.

This is happening despite official tightening from the BoJ. The monetary base is falling approximately 11.3% year on year. But the banking system is more than compensating: credit is growing, broad money is growing. Japanese investors purchased a net 10.3 billion yen in foreign bonds for the week ending May 23, a fourth consecutive week of positive flows, with no abrupt withdrawal of Japanese capital from international markets.

Block 2 Conclusion

The United States leads: M2, bank balance sheets and corporate lending are all expanding. Europe is stable but M3 posted its first monthly decline after several months of growth. China remains weak on credit impulse despite supportive policy. Japan shows accelerating credit and growing money supply despite official BoJ tightening. The global environment is stabilizing but not accelerating in unison.

Block 3: Market Liquidity and Credit Stress Indicators

Read more

Credit regime this week: RELAXED

After last week's warning signal, all five indicators relaxed in W22. MOVE pulled back below 70, credit spreads continued to tighten, and HYG/LQD held steady. The market confirmed that last week's spike in rate volatility was noise, not the start of a trend.

① MOVE Index | …

Read more

INTRODUCTION

In October 2022, something unusual happened to the portfolios of millions of investors around the world. It was not just equities that fell. Bonds fell too. Simultaneously. Over the course of one year, the S&P 500 lost nearly 20%, while long-duration US Treasuries, as measured by the TLT ETF, lost over 30%. The instrument that had served for decades as insurance against equity drawdowns collapsed harder than equities themselves.

For investors who had entered the market after 2000, it was a shock. For those familiar with market history before 1990, it was something else entirely: a deeply familiar feeling.

Markets have memory. Not in the sense that history repeats exactly. But in the sense that macro regimes return. And we may be at the beginning of exactly such a return.

THE FRAMEWORK OF JOHN MURPHY

John Murphy is one of the few market analysts who studies not just the movement of individual assets, but the relationships between them. In his book Intermarket Analysis, he describes something that most modern investors take for granted but that is, in fact, a historical exception: that stocks and bonds move in opposite directions.

Murphy shows that this inverse relationship is not a law of nature. It is the product of a specific macro regime that took hold in the late 1990s and dominated the following two decades. Before that, for more than thirty years, stocks and bonds frequently fell together. The reason is simple: when the market’s primary fear is inflation rather than growth, the two assets share the same enemy.

The distinction Murphy draws is as follows. In an inflationary environment, the primary risk to a portfolio comes from the price of money. When inflation rises, central banks raise rates, bond yields climb, bond prices fall, and equities suffer from a higher discount rate. Both assets face the same pressure. Their correlation is positive: they fall together.

In a disinflationary environment, the logic reverses. The primary risk is no longer inflation but growth. When the economy slows, equities fall, but the central bank has room to cut rates. Bonds appreciate. They become the natural safe haven. The correlation between stocks and bonds turns negative: when one falls, the other rises. It is precisely this logic on which the 60/40 portfolio, as we know it today, is built.

The key point is that this shift is not a technical footnote. It is a change in the entire macro regime.

THREE PERIODS

Period One: The Inflationary Regime (1965 – 1997)

To understand what an inflationary regime means in practice, one number is enough: the yield on 10-year US Treasuries reached nearly 16% in September 1981. Not because the economy was exceptionally strong. But because inflation had spiraled out of control and the Fed under Paul Volcker was forced to break expectations with record-high interest rates.

The path to that moment began in the mid-1960s. The combination of Vietnam War spending, the social programs of the Great Society, and two successive oil shocks in 1973 and 1979 created an environment in which inflation was structural, not temporary. During this period, stocks and bonds did not move as opposing forces. They moved as assets with a common enemy: higher interest rates. When inflation accelerated, yields rose, bond prices fell, and equities came under pressure from a higher discount rate and compressed margins.

The classic example is 1969: the S&P 500 lost around 11% while long-duration bonds simultaneously suffered from rising yields. Then 1973-74: the S&P lost nearly 48% amid the oil shock and stagflation, while bonds offered no real protection because inflationary risk dominated. Then 1977-78: simultaneous pressure on both assets again.

This is the world in which the 60/40 portfolio does not work as diversification. Bonds do not put out the fire in equities. They burn alongside them.

Period Two: The Disinflationary Regime (1990 – 2021)

The history of the disinflationary regime does not begin with a single event. It begins with two, separated by seven years, that together created the conditions for the longest and most stable market environment in modern history. But to understand how this regime was born, we need to take one step further back.

To understand the origins of the disinflationary regime, we must start with Volcker. When Paul Volcker raised interest rates to nearly 20% in the early 1980s, he broke inflation. But the side effect was a massively strong dollar. The DXY, the US Dollar Index, reached its all-time historical peak of around 164 in 1985.

The dollar had become so strong that developing economies carrying dollar-denominated debt were under enormous pressure. The response came in September 1985 with the Plaza Accord: the G5 agreed to deliberately devalue the dollar, forcing a sharp appreciation of the yen. In response, Japan leaned into domestic monetary easing and credit expansion, which helped inflate one of the largest real estate and equity bubbles in modern history. When the Bank of Japan tightened policy in the late 1980s, the bubble burst. Volcker had cured inflation. But the medicine had sown the seeds of the next regime.

The first event is Japan. In 1990, the Japanese equity bubble burst. This was not an ordinary bear market. It was the beginning of a 13-year decline that gradually became a deflationary spiral in what was then the world’s second-largest economy. The Japanese economy entered a regime in which prices fell, growth stalled, and the central bank lost its ability to stimulate through conventional tools. Western central bankers studied the Japanese deflationary model with growing anxiety, searching for ways to prevent the same from happening in their own economies.

The second event is the Asian financial crisis of 1997-98. The collapse of the Thai baht triggered a chain reaction in South Korea, Indonesia, Malaysia, and Hong Kong. But the market effect extended far beyond Asia. The crisis sent a powerful deflationary impulse into the global economy: cheap Asian goods and devalued currencies flooded world markets, pushing prices down. Murphy calls this the “Asian contagion” and argues that more than any other single factor, it was this that changed a key intermarket relationship.

Until 1998, the word “deflation” had not been heard seriously since the 1930s. After 1998, it began to define the logic of markets.

This is where the “decoupling” Murphy describes takes place: the normal relationship between bonds and equities disappears and reverses. Until this point, the two assets had generally moved in the same direction because they shared a common enemy: inflation and interest rates. After 1998, they began moving in opposite directions. Bonds became a refuge precisely when equities were suffering.

It is important, however, to draw a distinction that Murphy emphasizes explicitly. Disinflation, meaning the slowing of inflation, is good for both bonds and equities. Interest rates fall, bond prices rise, and equities perform well as long as the economy is still growing. But when falling rates are a symptom of economic weakness rather than strength, the picture changes. This is precisely what we see in the two bear markets of 2000 and 2007: bond yields fell, but equities fell alongside them rather than in the opposite direction.

Within the disinflationary regime that consolidated after 1998, the 60/40 portfolio performed exceptionally well. Inflation remained low and controlled. The Fed had room to cut rates at every shock. The policy put was real and predictable. In every crisis, 2001, 2008, 2011, 2015, even 2020, bonds appreciated when equities fell. The negative correlation looked like a law of nature. For an investor who entered the market after 2000, it simply was. It had always been. And it always would be.

Until 2022 arrived.

Period Three: The Return? (2022 – Present)

To understand why 2022 was not an accident, we need to look back not years but decades. Because the conditions that produced the inflationary regime of the 1960s and 70s reproduced themselves in a strikingly similar form.

In the 1960s and 70s, the combination was: massive fiscal expansion through Vietnam War spending and the Great Society social programs, monetary policy that financed those deficits, and two successive oil shocks in 1973 and 1979 that added powerful supply-side inflationary pressure. The result: inflation was not temporary. It was structural.

Now look at the period after 2008. The financial crisis forced the Fed to expand its balance sheet from roughly $900 billion to over $4.5 trillion through QE1, QE2, and QE3. Rates stayed at zero for nearly a decade. Then came Covid: the Fed’s balance sheet jumped to nearly $9 trillion in a matter of months, governments deployed trillions in fiscal stimulus, and global supply chains snapped simultaneously. Then came Ukraine and the energy shock.

The parallel is not coincidental. In both cases, the same combination: prolonged monetary and fiscal expansion followed by an external supply shock. The difference is only in the instruments. In the 1960s, direct money creation for war and social programs. After 2008, zero rates and QE for a decade, followed by fiscal bazookas during Covid. The mechanism is identical. So is the result.

And here lies the deep irony of macro regimes. Bernanke and the post-2008 Fed had studied the Japanese deflationary spiral precisely in order not to repeat it. QE1, QE2, and QE3 were a direct response to the lesson from Japan: when facing deflationary risk, do not hesitate, act aggressively, and provide liquidity. Zero rates for a decade were a deliberate choice against deflation. They worked. Deflation did not happen. But zero rates for a decade inflated new bubbles, created structural dependency on cheap money, and left the system without a buffer when the supply shock hit. Bernanke cured deflation. But the medicine sowed the seeds of inflation. Every regime carries within it the embryo of the next.

2022 was the first serious warning that the regime may have changed. For the first time in decades, investors saw a simultaneous decline in both stocks and bonds of real magnitude: S&P 500 minus 19%, TLT minus 31% within a single calendar year. It was not a technical anomaly. It was the logical consequence of inflation not seen in advanced economies for 40 years, and a Fed forced to respond with the fastest tightening cycle since the Volcker era.

The question now is not whether 2022 was an accident. The question is whether the structural disinflationary forces of the past three decades are still strong enough. Globalization is reversing. Geopolitical fragmentation is raising supply chain costs. Asian demographics no longer produce the same deflationary pressure. Energy insecurity around the Strait of Hormuz adds structural inflationary risk.

We are not saying we are returning exactly to 1975. We are saying something more precise: the structural conditions that made disinflation almost automatic are weakening. And in such an environment, the correlation between stocks and bonds may shift back toward positive territory, just as it was before 1997.

THE TRANSMISSION MECHANISM AND THE CURRENT CRISIS

Geopolitical shocks do not move markets by themselves. Markets move from the liquidity and inflationary response to those shocks. The same geopolitical shock can have an entirely different market impact depending on the macro regime in which it occurs.

If the shock occurs in a disinflationary environment, where inflation is low and the central bank has room to respond, the market treats it as a recessionary risk. Equities fall, bonds rally, the Fed cuts rates. The classic risk-off. This is precisely how most geopolitical crises played out after 1998.

If the shock occurs in an environment where inflation is already elevated and the central bank lacks the same freedom, the logic changes fundamentally. The market no longer asks only “how large is the shock?” It asks “will this shock force central banks to remain more hawkish than investors expected?”

This is precisely the second situation we now face.

The mechanism can be described as a sequential chain: tension around the Strait of Hormuz pushes oil and energy prices higher. Higher energy feeds directly into headline inflation. Headline inflation pushes inflation expectations higher. Higher inflation expectations push nominal bond yields higher. Higher yields push bond prices lower. And higher yields compress equity multiples, because the discount rate rises.

This is the chain that makes the current situation different from ordinary risk-off. In a classic risk-off shock, investors sell equities and buy bonds. That logic works only when the shock is deflationary in nature: banking stress, a consumption collapse, recessionary risk. Then the market expects the central bank to cut rates and bonds benefit.

An energy shock from the Middle East is different in nature. It can simultaneously depress real growth and push headline inflation higher. This is the uncomfortable combination: the economy weakens, but inflation prevents the central bank from responding aggressively. The result is stagflationary logic: equities suffer from weaker growth and higher costs, while bonds suffer from higher inflation expectations and a higher term premium. Both sides of the 60/40 portfolio are under pressure simultaneously.

This is the moment when the market begins to fear not simply high oil prices, but something deeper: the loss of the policy put. In the disinflationary regime of recent decades, investors had grown accustomed to the idea that at every sufficiently large shock, the central bank would cut rates, provide liquidity, and stabilize the system. That insurance worked because inflation was low and the Fed had room to act.

In an inflationary supply shock, that insurance disappears. The central bank may see deteriorating growth, but if inflation expectations are rising, it does not have the same freedom to respond. It is forced to hold rates high or even speak more hawkishly to prevent second-round effects on wages, prices, and expectations. This is precisely the regime Murphy describes as inflationary: when the market’s primary fear is not growth but the price of money.

THE DATA IS ALREADY MOVING IN THIS DIRECTION

Everything described above is not theory. The data from recent months paints a picture that is difficult to ignore.

Start with inflation expectations. Not the official CPI, but what households and markets expect to happen over the next five years. The Michigan Survey, one of the most closely watched indicators of long-term inflation sentiment in the US, registered 5-year expectations of 3.9%. One-year expectations for the eurozone reached 4%. These are not noisy short-term reactions to an oil shock. Long-term expectations move slowly and are sticky. When they move higher and hold, the market sends a clear signal: confidence in central banks’ ability to return inflation to target is being depleted.

Then look at producer prices. US PPI rose 6.0% year-on-year in April 2026, with a 1.4% monthly increase marking the fastest one-month rise since March 2022. Japanese producer prices show a similar trajectory. European ones too. Producer prices matter because they are a leading indicator: what enters production today exits as consumer inflation tomorrow. The chain has not finished transmitting.

Then look at the long ends of bond markets around the world. The yield on 30-year UK gilts stands at 5.82%. Australian equivalents are at 5.51%. Japanese 30-year bonds, traditionally the symbol of the deflationary era, now yield 4.00%, having risen by more than 100 basis points over the past year alone, the sharpest move among developed economies. This is not an American problem. It is a global repricing of long-term inflationary and fiscal risk.

And finally, perhaps the most important signal comes not from the data but from the people who manage the money. Mohamed El-Erian, chief economic adviser at Allianz and one of the most closely followed macro voices in the world, published a direct thesis in the Financial Times at the end of May 2026: investors can no longer rely on the policy put. For three decades, central banks intervened at every instance of market stress, not only at systemic crises but at ordinary selloffs. This practice built a deep market psychology in which volatility was perceived not as a signal of a fundamental problem but as an automatic buying opportunity. Now, El-Erian argues, the equation has changed. The inflationary reality places central banks before a stark choice: stabilize financial assets or protect their long-term credibility. In an inflationary supply shock, the two cannot happen simultaneously.

Taken together, these data points do not prove we are in a new inflationary regime. They prove something more precise: the market no longer takes the disinflationary regime for granted. And when the market stops taking something for granted, its behavior changes before the official data confirms it.

THE PRACTICAL CONCLUSION FOR PORTFOLIOS

The biggest mistake an investor can make in this environment is the mechanical assumption that bonds always diversify equities. That assumption is not a universal truth. It is the product of a specific macro regime that dominated from 1998 to 2021. Within that regime, it worked perfectly. But the regime in which it worked may no longer be in place.

The key question for any portfolio right now is not “how many bonds should I hold?” The question is “which risk dominates right now: inflationary or growth?”

If the market is trading recessionary fear, falling growth, and anticipated rate cuts, long duration works. Bonds appreciate, the correlation with equities remains negative, and 60/40 performs well. This is precisely how the crises of 2001, 2008, and 2020 played out.

If the market is trading an energy shock, sticky inflation, and higher-for-longer, long duration may increase the drawdown rather than reduce it. Equities suffer from weaker growth and compressed margins, while bonds suffer from higher inflation expectations and a rising term premium. Both sides of the 60/40 portfolio are under pressure simultaneously. This is precisely how 1973-74 and 2022 played out.

This means that the stock-bond correlation is not a parameter set once and forgotten. It is an indicator of the macro regime. When it shifts toward positive territory, the market is sending a signal: I am no longer afraid only of growth. I am afraid of inflation, interest rates, and the reaction of central banks.

What should an investor specifically monitor? Three indicators provide the earliest signal of the regime’s direction. The first is break-even inflation expectations, meaning the spread between nominal and real yields on TIPS bonds. When these expectations rise persistently, the market is pricing inflationary risk, not growth risk. The second is term premium, the additional compensation investors require for the risk of holding long-duration bonds. When term premium rises, the market does not believe inflation will return quickly to target. The third is the movement of the long end globally. When UK, Japanese, and Australian long-duration bonds move in the same direction simultaneously, that is not local noise. It is a global regime signal.

FINAL THESIS

John Murphy describes a regime change not as a catastrophic event but as a gradual shift in the logic of markets. First, anomalies appear, correlations that do not behave as investors expect. Then the anomalies become more frequent. Then the new logic establishes itself as the norm, and the next generation of investors takes it for granted.

We are living in a moment when the anomalies are already visible. 2022 was a warning. The global rise in long-duration yields is a continuation. Inflation expectations stuck above target are a confirmation. The loss of the policy put is the consequence.

The current crisis around Hormuz matters not because every geopolitical shock automatically collapses markets. It matters because it arrives at a moment when structural disinflationary forces are weakening, inflation expectations are already becoming unanchored, and central banks do not have the same freedom to respond that they had between 1998 and 2021.

If the shock remains contained, oil normalizes, and inflation returns to target, the market may return to disinflationary logic. Bonds will work again as a hedge. 60/40 will perform well.

But if the shock keeps energy elevated, inflation expectations continue rising, and central banks remain hawkish for longer than expected, then bonds will not be the automatic protection against equity drawdowns. They will be part of the problem itself.

This is the essence of what Murphy describes: the relationship between stocks and bonds is determined by the market’s primary fear. In a disinflationary world, the fear is growth. In an inflationary world, the fear is the price of money. And when the price of money rises, both bonds and equities can fall together.

The shock is not dangerous in itself. It is dangerous if it transforms geopolitical risk into an inflationary regime. Then the old rules stop applying. And investors accustomed to the logic of the past twenty-five years will have to learn something that the generation before them knew very well.

SOURCES

• Financial Times: “Investors can no longer rely on a ‘policy put’” – Mohamed El-Erian, May 27, 2026

• Reuters: Yields surge to one-year highs as oil prices and inflation data rattle markets, May 15, 2026

• Reuters: US annual consumer inflation posts largest gain in three months, May 12, 2026

• Reuters: US producer prices surprise with largest increase in four years, May 13, 2026

• Federal Reserve: “Good” Inflation, “Bad” Inflation: Implications for Risky Asset Prices

• PGIM: Stock-Bond Correlation: A Global Perspective

• Vanguard: The stock-bond correlation: increasing amid inflation, but not a regime change

• John Murphy: Intermarket Analysis